-
1
-
-
0015243053
-
Effects of marihuana on the solution of anagrams, memory and appetite
-
Abel E.L. Effects of marihuana on the solution of anagrams, memory and appetite. Nature 1971, 231:260-261.
-
(1971)
Nature
, vol.231
, pp. 260-261
-
-
Abel, E.L.1
-
2
-
-
0016621840
-
Cannabis: Effects on hunger and thirst
-
Abel E.L. Cannabis: Effects on hunger and thirst. Behavioral Biology 1975, 15:255-281.
-
(1975)
Behavioral Biology
, vol.15
, pp. 255-281
-
-
Abel, E.L.1
-
3
-
-
0031028923
-
Isolation and expression of a mouse CB1 cannabinoid receptor gene: Comparison of binding properties with those of native CB1 receptors in mouse brain and n18tg2 neuroblastoma cells
-
Abood M.E., Ditto K.E., Noel M.A., Showalter V.M., Tao Q. Isolation and expression of a mouse CB1 cannabinoid receptor gene: Comparison of binding properties with those of native CB1 receptors in mouse brain and n18tg2 neuroblastoma cells. Biochemical Pharmacology 1997, 53:207-214.
-
(1997)
Biochemical Pharmacology
, vol.53
, pp. 207-214
-
-
Abood, M.E.1
Ditto, K.E.2
Noel, M.A.3
Showalter, V.M.4
Tao, Q.5
-
4
-
-
0021124870
-
Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds
-
Allyn C. Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds. Life Sciences 1984, 35:1803-1810.
-
(1984)
Life Sciences
, vol.35
, pp. 1803-1810
-
-
Allyn, C.1
-
5
-
-
1842582870
-
AMP-activated protein kinase plays a role in the control of food intake
-
Andersson U., Filipsson K., Abbott C.R., Woods A., Smith K., Bloom S.R., et al. AMP-activated protein kinase plays a role in the control of food intake. The Journal of Biological Chemistry 2004, 279:12005-12008.
-
(2004)
The Journal of Biological Chemistry
, vol.279
, pp. 12005-12008
-
-
Andersson, U.1
Filipsson, K.2
Abbott, C.R.3
Woods, A.4
Smith, K.5
Bloom, S.R.6
-
6
-
-
0030738512
-
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors
-
Arnone M., Maruani J., Chaperon F., Thiébot M.H., Poncelet M., Soubrié P., et al. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 1997, 132:104-106.
-
(1997)
Psychopharmacology
, vol.132
, pp. 104-106
-
-
Arnone, M.1
Maruani, J.2
Chaperon, F.3
Thiébot, M.H.4
Poncelet, M.5
Soubrié, P.6
-
7
-
-
79951672612
-
Effects of cannabinoids on neuropeptide Y and β-endorphin expression in the rat hypothalamic arcuate nucleus
-
Bakkali-Kassemi L., El Ouezzani S., Magoul R., Merroun I., Lopez-Jurado M., Errami M. Effects of cannabinoids on neuropeptide Y and β-endorphin expression in the rat hypothalamic arcuate nucleus. The British Journal of Nutrition 2011, 105:654-660.
-
(2011)
The British Journal of Nutrition
, vol.105
, pp. 654-660
-
-
Bakkali-Kassemi, L.1
El Ouezzani, S.2
Magoul, R.3
Merroun, I.4
Lopez-Jurado, M.5
Errami, M.6
-
8
-
-
0028935579
-
Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
-
Beal J.E., Olson R., Laubenstein L., Morales J.O., Bellman P., Yangco B., et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. Journal of Pain and Symptom Management 1995, 10:89-97.
-
(1995)
Journal of Pain and Symptom Management
, vol.10
, pp. 89-97
-
-
Beal, J.E.1
Olson, R.2
Laubenstein, L.3
Morales, J.O.4
Bellman, P.5
Yangco, B.6
-
9
-
-
81155134826
-
Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss
-
Bennetzen M.F., Wellner N., Ahmed S.S., Ahmed S.M., Diep T.A., Hansen H.S., et al. Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss. International Journal of Obesity 2011, 35:1377-1384.
-
(2011)
International Journal of Obesity
, vol.35
, pp. 1377-1384
-
-
Bennetzen, M.F.1
Wellner, N.2
Ahmed, S.S.3
Ahmed, S.M.4
Diep, T.A.5
Hansen, H.S.6
-
10
-
-
0037374766
-
The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells
-
Bensaid M., Gary-Bobo M., Esclangon A., Maffrand J.P., Le Fur G., Oury-Donat F., et al. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Molecular Pharmacology 2003, 63:908-914.
-
(2003)
Molecular Pharmacology
, vol.63
, pp. 908-914
-
-
Bensaid, M.1
Gary-Bobo, M.2
Esclangon, A.3
Maffrand, J.P.4
Le Fur, G.5
Oury-Donat, F.6
-
11
-
-
39049091518
-
Presence of functional cannabinoid receptors in human endocrine pancreas
-
Bermúdez-Silva F., Suárez J., Baixeras E., Cobo N., Bautista D., Cuesta-Muñoz A., et al. Presence of functional cannabinoid receptors in human endocrine pancreas. Diabetologia 2008, 51:476-487.
-
(2008)
Diabetologia
, vol.51
, pp. 476-487
-
-
Bermúdez-Silva, F.1
Suárez, J.2
Baixeras, E.3
Cobo, N.4
Bautista, D.5
Cuesta-Muñoz, A.6
-
12
-
-
0033198288
-
Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period
-
Berrendero F., Sepe N., Ramos J.A., Di Marzo V., Fernàndez-Ruiz J.J. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 1999, 33:181-191.
-
(1999)
Synapse
, vol.33
, pp. 181-191
-
-
Berrendero, F.1
Sepe, N.2
Ramos, J.A.3
Di Marzo, V.4
Fernàndez-Ruiz, J.J.5
-
13
-
-
0036669295
-
Tetrahydrocannabinol and endocannabinoids in feeding and appetite
-
Berry E.M., Mechoulam R. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacology & Therapeutics 2002, 95:185-190.
-
(2002)
Pharmacology & Therapeutics
, vol.95
, pp. 185-190
-
-
Berry, E.M.1
Mechoulam, R.2
-
14
-
-
10744229235
-
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
-
Bisogno T., Howell F., Williams G., Minassi A., Cascio M.G., Ligresti A., et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. The Journal of Cell Biology 2003, 163:463-468.
-
(2003)
The Journal of Cell Biology
, vol.163
, pp. 463-468
-
-
Bisogno, T.1
Howell, F.2
Williams, G.3
Minassi, A.4
Cascio, M.G.5
Ligresti, A.6
-
15
-
-
33845522074
-
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity
-
Bláher M., Engeli S., KlÖting N., Berndt J., Fasshauer M., Bátkai S., et al. Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 2006, 55:3053-3060.
-
(2006)
Diabetes
, vol.55
, pp. 3053-3060
-
-
Bláher, M.1
Engeli, S.2
Klöting, N.3
Berndt, J.4
Fasshauer, M.5
Bátkai, S.6
-
16
-
-
72549092662
-
Novel thioamide derivatives as neutral CB1 receptor antagonists
-
BostrÖm J., Olsson R.I., Tholander J., Greasley P.J., Ryberg E., Nordberg H., et al. Novel thioamide derivatives as neutral CB1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2010, 20:479-482.
-
(2010)
Bioorganic & Medicinal Chemistry Letters
, vol.20
, pp. 479-482
-
-
Boström, J.1
Olsson, R.I.2
Tholander, J.3
Greasley, P.J.4
Ryberg, E.5
Nordberg, H.6
-
17
-
-
22144477527
-
Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation
-
Bouaboula M., Hilairet S., Marchand J., Fajas L., Fur G.L., Casellas P. Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation. European Journal of Pharmacology 2005, 517:174-181.
-
(2005)
European Journal of Pharmacology
, vol.517
, pp. 174-181
-
-
Bouaboula, M.1
Hilairet, S.2
Marchand, J.3
Fajas, L.4
Fur, G.L.5
Casellas, P.6
-
18
-
-
2142815151
-
Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity
-
Bray G.A., Nielsen S.J., Popkin B.M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. The American Journal of Clinical Nutrition 2004, 79:537-543.
-
(2004)
The American Journal of Clinical Nutrition
, vol.79
, pp. 537-543
-
-
Bray, G.A.1
Nielsen, S.J.2
Popkin, B.M.3
-
19
-
-
0032589999
-
Chronic D9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain
-
Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., Vogt L.J., Sim-Selley L.J. Chronic D9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. Journal of Neurochemistry 1999, 73:2447-2459.
-
(1999)
Journal of Neurochemistry
, vol.73
, pp. 2447-2459
-
-
Breivogel, C.S.1
Childers, S.R.2
Deadwyler, S.A.3
Hampson, R.E.4
Vogt, L.J.5
Sim-Selley, L.J.6
-
20
-
-
0034948614
-
Evidence for a new G protein-coupled cannabinoid receptor in mouse brain
-
Breivogel C.S., Griffin G., Di Marzo V., Martin B.R. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Molecular Pharmacology 2001, 60:155-163.
-
(2001)
Molecular Pharmacology
, vol.60
, pp. 155-163
-
-
Breivogel, C.S.1
Griffin, G.2
Di Marzo, V.3
Martin, B.R.4
-
21
-
-
0017645859
-
Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of Δ9-tetrahydrocannabinol
-
Brown J.E., Kassouny M., Cross J.K. Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of Δ9-tetrahydrocannabinol. Behavioral Biology 1977, 20:104-110.
-
(1977)
Behavioral Biology
, vol.20
, pp. 104-110
-
-
Brown, J.E.1
Kassouny, M.2
Cross, J.K.3
-
22
-
-
0031594480
-
Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat
-
Buckley N.E., Hansson S., Harta G., Mezey é. Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience 1997, 82:1131-1149.
-
(1997)
Neuroscience
, vol.82
, pp. 1131-1149
-
-
Buckley, N.E.1
Hansson, S.2
Harta, G.3
Mezey, É.4
-
23
-
-
0034685707
-
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
-
Buckley N.E., McCoy K.L., Mezey E., Bonner T., Zimmer A., Felder C.C., et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor. European Journal of Pharmacology 2000, 396:141-149.
-
(2000)
European Journal of Pharmacology
, vol.396
, pp. 141-149
-
-
Buckley, N.E.1
McCoy, K.L.2
Mezey, E.3
Bonner, T.4
Zimmer, A.5
Felder, C.C.6
-
24
-
-
67650531422
-
Thematic review series: Proteomics. An integrated omics analysis of eicosanoid biology
-
Buczynski M.W., Dumlao D.S., Dennis E.A. Thematic review series: Proteomics. An integrated omics analysis of eicosanoid biology. Journal of Lipid Research 2009, 50:1015-1038.
-
(2009)
Journal of Lipid Research
, vol.50
, pp. 1015-1038
-
-
Buczynski, M.W.1
Dumlao, D.S.2
Dennis, E.A.3
-
25
-
-
0032968566
-
Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor
-
Calandra B., Portier M., Kernéis A., Delpech M., Carillon C., Le Fur G., et al. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor. European Journal of Pharmacology 1999, 374:445-455.
-
(1999)
European Journal of Pharmacology
, vol.374
, pp. 445-455
-
-
Calandra, B.1
Portier, M.2
Kernéis, A.3
Delpech, M.4
Carillon, C.5
Le Fur, G.6
-
26
-
-
12244266462
-
Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract
-
Casu M.A., Porcella A., Ruiu S., Saba P., Marchese G., Carai M.A.M., et al. Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract. European Journal of Pharmacology 2003, 459:97-105.
-
(2003)
European Journal of Pharmacology
, vol.459
, pp. 97-105
-
-
Casu, M.A.1
Porcella, A.2
Ruiu, S.3
Saba, P.4
Marchese, G.5
Carai, M.A.M.6
-
27
-
-
41249100938
-
Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor
-
Chen R.Z., Frassetto A., Lao J.Z., Huang R.R., Xiao J.C., Clements M.J., et al. Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor. European Journal of Pharmacology 2008, 584:338-342.
-
(2008)
European Journal of Pharmacology
, vol.584
, pp. 338-342
-
-
Chen, R.Z.1
Frassetto, A.2
Lao, J.Z.3
Huang, R.R.4
Xiao, J.C.5
Clements, M.J.6
-
28
-
-
77956037652
-
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents
-
Cluny N.L., Vemuri V.K., Chambers A.P., Limebeer C.L., Bedard H., Wood J.T., et al. A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents. British Journal of Pharmacology 2010, 161:629-642.
-
(2010)
British Journal of Pharmacology
, vol.161
, pp. 629-642
-
-
Cluny, N.L.1
Vemuri, V.K.2
Chambers, A.P.3
Limebeer, C.L.4
Bedard, H.5
Wood, J.T.6
-
29
-
-
33750374137
-
The twentieth century struggle to decipher insulin signalling
-
Cohen P. The twentieth century struggle to decipher insulin signalling. Nature Reviews. Molecular Cell Biology 2006, 7:867-873.
-
(2006)
Nature Reviews. Molecular Cell Biology
, vol.7
, pp. 867-873
-
-
Cohen, P.1
-
30
-
-
0033559313
-
Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp
-
Cohen S., Dadi H., Shaoul E., Sharfe N., Roifman C.M. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 1999, 93:2013-2024.
-
(1999)
Blood
, vol.93
, pp. 2013-2024
-
-
Cohen, S.1
Dadi, H.2
Shaoul, E.3
Sharfe, N.4
Roifman, C.M.5
-
31
-
-
0025800169
-
The actions of cyclic AMP on biosynthetic processes are mediated indirectly by cyclic AMP-dependent protein kinase
-
Cohen P., Grahame Hardie D. The actions of cyclic AMP on biosynthetic processes are mediated indirectly by cyclic AMP-dependent protein kinase. Biochimica et Biophysica Acta 1991, 1094:292-299.
-
(1991)
Biochimica et Biophysica Acta
, vol.1094
, pp. 292-299
-
-
Cohen, P.1
Grahame Hardie, D.2
-
32
-
-
0032541111
-
Appetite suppression and weight loss after the cannabinoid antagonist SR 141716
-
Colombo G., Agabio R., Diaz G., Lobina C., Reali R., Gessa G.L. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sciences 1998, 63:L113-L117.
-
(1998)
Life Sciences
, vol.63
-
-
Colombo, G.1
Agabio, R.2
Diaz, G.3
Lobina, C.4
Reali, R.5
Gessa, G.L.6
-
33
-
-
0030423694
-
In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): Inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity
-
Compton D.R., Aceto M.D., Lowe J., Martin B.R. In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): Inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. The Journal of Pharmacology and Experimental Therapeutics 1996, 277:586-594.
-
(1996)
The Journal of Pharmacology and Experimental Therapeutics
, vol.277
, pp. 586-594
-
-
Compton, D.R.1
Aceto, M.D.2
Lowe, J.3
Martin, B.R.4
-
34
-
-
85047690626
-
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
-
Cota D., Marsicano G., TschÖp M., Grábler Y., Flachskamm C., Schubert M., et al. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. The Journal of Clinical Investigation 2003, 112:423-431.
-
(2003)
The Journal of Clinical Investigation
, vol.112
, pp. 423-431
-
-
Cota, D.1
Marsicano, G.2
Tschöp, M.3
Grábler, Y.4
Flachskamm, C.5
Schubert, M.6
-
35
-
-
0042422112
-
Xenopus laevis CB1 cannabinoid receptor: Molecular cloning and mRNA distribution in the central nervous system
-
Cottone E., Salio C., Conrath M., Franzoni M.F. Xenopus laevis CB1 cannabinoid receptor: Molecular cloning and mRNA distribution in the central nervous system. The Journal of Comparative Neurology 2003, 464:487-496.
-
(2003)
The Journal of Comparative Neurology
, vol.464
, pp. 487-496
-
-
Cottone, E.1
Salio, C.2
Conrath, M.3
Franzoni, M.F.4
-
36
-
-
0035979244
-
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
-
Cravatt B.F., Demarest K., Patricelli M.P., Bracey M.H., Giang D.K., Martin B.R., et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proceedings of the National Academy of Sciences 2001, 98:9371-9376.
-
(2001)
Proceedings of the National Academy of Sciences
, vol.98
, pp. 9371-9376
-
-
Cravatt, B.F.1
Demarest, K.2
Patricelli, M.P.3
Bracey, M.H.4
Giang, D.K.5
Martin, B.R.6
-
37
-
-
0029904838
-
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
-
Cravatt B.F., Giang D.K., Mayfield S.P., Boger D.L., Lerner R.A., Gilula N.B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996, 384:83-87.
-
(1996)
Nature
, vol.384
, pp. 83-87
-
-
Cravatt, B.F.1
Giang, D.K.2
Mayfield, S.P.3
Boger, D.L.4
Lerner, R.A.5
Gilula, N.B.6
-
38
-
-
0028084259
-
Downregulation of rat brain cannabinoid binding sites after chronic D9-tetrahydrocannabinol treatment
-
De Fonseca F.R., Gorriti M.A., Fernández-Ruiz J.J., Palomo T., Ramos J.A. Downregulation of rat brain cannabinoid binding sites after chronic D9-tetrahydrocannabinol treatment. Pharmacology, Biochemistry, and Behavior 1994, 47:33-40.
-
(1994)
Pharmacology, Biochemistry, and Behavior
, vol.47
, pp. 33-40
-
-
De Fonseca, F.R.1
Gorriti, M.A.2
Fernández-Ruiz, J.J.3
Palomo, T.4
Ramos, J.A.5
-
39
-
-
27844463517
-
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
-
Després J.P., Golay A., SjÖstrÖm L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. The New England Journal of Medicine 2005, 353:2121-2134.
-
(2005)
The New England Journal of Medicine
, vol.353
, pp. 2121-2134
-
-
Després, J.P.1
Golay, A.2
Sjöström, L.3
-
40
-
-
61549116530
-
Effect of rimonabant on the high-triglyceride/low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat
-
for the ADAGIO-Lipids Investigators
-
Després J.P., Ross R., Boka G., Alméras N., Lemieux I., for the ADAGIO-Lipids Investigators Effect of rimonabant on the high-triglyceride/low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat. Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 29:416-423.
-
(2009)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.29
, pp. 416-423
-
-
Després, J.P.1
Ross, R.2
Boka, G.3
Alméras, N.4
Lemieux, I.5
-
41
-
-
0024263922
-
Determination and characterization of a cannabinoid receptor in rat brain
-
Devane W.A., Dysarz F.A., Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Molecular Pharmacology 1988, 34:605-613.
-
(1988)
Molecular Pharmacology
, vol.34
, pp. 605-613
-
-
Devane, W.A.1
Dysarz, F.A.2
Johnson, M.R.3
Melvin, L.S.4
Howlett, A.C.5
-
42
-
-
0027078685
-
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
-
Devane W.A., HanuS L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258:1946-1949.
-
(1992)
Science
, vol.258
, pp. 1946-1949
-
-
Devane, W.A.1
HanuS, L.2
Breuer, A.3
Pertwee, R.G.4
Stevenson, L.A.5
Griffin, G.6
-
43
-
-
48249097797
-
Endocannabinoids: Synthesis and degradation
-
Springer: Berlin/Heidelberg
-
Di Marzo V. Endocannabinoids: Synthesis and degradation. Reviews of Physiology Biochemistry and Pharmacology 2008, 160:1-24. Springer: Berlin/Heidelberg.
-
(2008)
Reviews of Physiology Biochemistry and Pharmacology
, vol.160
, pp. 1-24
-
-
Di Marzo, V.1
-
44
-
-
43249100162
-
Targeting the endocannabinoid system: To enhance or reduce?
-
Di Marzo V. Targeting the endocannabinoid system: To enhance or reduce?. Nature Reviews. Drug Discovery 2008, 7:438-455.
-
(2008)
Nature Reviews. Drug Discovery
, vol.7
, pp. 438-455
-
-
Di Marzo, V.1
-
45
-
-
0033769188
-
Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice
-
Di Marzo V., Breivogel C.S., Tao Q., Bridgen D.T., Razdan R.K., Zimmer A.M., et al. Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice. Journal of Neurochemistry 2000, 75:2434-2444.
-
(2000)
Journal of Neurochemistry
, vol.75
, pp. 2434-2444
-
-
Di Marzo, V.1
Breivogel, C.S.2
Tao, Q.3
Bridgen, D.T.4
Razdan, R.K.5
Zimmer, A.M.6
-
46
-
-
58149471799
-
Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: Associations with changes in metabolic risk factors
-
Di Marzo V., Côté M., Matias I., Lemieux I., Arsenault B., Cartier A., et al. Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: Associations with changes in metabolic risk factors. Diabetologia 2009, 52:213-217.
-
(2009)
Diabetologia
, vol.52
, pp. 213-217
-
-
Di Marzo, V.1
Côté, M.2
Matias, I.3
Lemieux, I.4
Arsenault, B.5
Cartier, A.6
-
47
-
-
70350347327
-
CB1 antagonists for obesity-What lessons have we learned from rimonabant?
-
Di Marzo V., Després J.P. CB1 antagonists for obesity-What lessons have we learned from rimonabant?. Nature Reviews. Endocrinology 2009, 5:633-638.
-
(2009)
Nature Reviews. Endocrinology
, vol.5
, pp. 633-638
-
-
Di Marzo, V.1
Després, J.P.2
-
48
-
-
0028589390
-
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
-
Di Marzo V., Fontana A., Cadas H., Schinelli S., Cimino G., Schwartz J.C., et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372:686-691.
-
(1994)
Nature
, vol.372
, pp. 686-691
-
-
Di Marzo, V.1
Fontana, A.2
Cadas, H.3
Schinelli, S.4
Cimino, G.5
Schwartz, J.C.6
-
49
-
-
0035848818
-
Leptin-regulated endocannabinoids are involved in maintaining food intake
-
Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 2001, 410:822-825.
-
(2001)
Nature
, vol.410
, pp. 822-825
-
-
Di Marzo, V.1
Goparaju, S.K.2
Wang, L.3
Liu, J.4
Batkai, S.5
Jarai, Z.6
-
50
-
-
0035881542
-
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells
-
Di Marzo V., Melck D., Orlando P., Bisogno T., Zagoory O., Bifulco M., et al. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. The Biochemical Journal 2001, 358:249-255.
-
(2001)
The Biochemical Journal
, vol.358
, pp. 249-255
-
-
Di Marzo, V.1
Melck, D.2
Orlando, P.3
Bisogno, T.4
Zagoory, O.5
Bifulco, M.6
-
51
-
-
0343252918
-
Trick or treat from food endocannabinoids?
-
Di Marzo V., Sepe N., De Petrocellis L., Berger A., Crozier G., Fride E., et al. Trick or treat from food endocannabinoids?. Nature 1998, 396:636.
-
(1998)
Nature
, vol.396
, pp. 636
-
-
Di Marzo, V.1
Sepe, N.2
De Petrocellis, L.3
Berger, A.4
Crozier, G.5
Fride, E.6
-
52
-
-
0036678094
-
Brain monoglyceride lipase participating in endocannabinoid inactivation
-
Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proceedings of the National Academy of Sciences 2002, 99:10819-10824.
-
(2002)
Proceedings of the National Academy of Sciences
, vol.99
, pp. 10819-10824
-
-
Dinh, T.P.1
Carpenter, D.2
Leslie, F.M.3
Freund, T.F.4
Katona, I.5
Sensi, S.L.6
-
53
-
-
79961239911
-
Endocannabinoid signal in the gut controls dietary fat intake
-
DiPatrizio N.V., Astarita G., Schwartz G., Li X., Piomelli D. Endocannabinoid signal in the gut controls dietary fat intake. Proceedings of the National Academy of Sciences 2011, 108:12904-12908.
-
(2011)
Proceedings of the National Academy of Sciences
, vol.108
, pp. 12904-12908
-
-
DiPatrizio, N.V.1
Astarita, G.2
Schwartz, G.3
Li, X.4
Piomelli, D.5
-
54
-
-
38349136266
-
Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial
-
Dixon J.B., O'Brien P.E., Playfair J., Chapman L., Schachter L.M., Skinner S., et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: A randomized controlled trial. JAMA: The Journal of the American Medical Association 2008, 299:316-323.
-
(2008)
JAMA: The Journal of the American Medical Association
, vol.299
, pp. 316-323
-
-
Dixon, J.B.1
O'Brien, P.E.2
Playfair, J.3
Chapman, L.4
Schachter, L.M.5
Skinner, S.6
-
55
-
-
79955921999
-
The differential effect of CB1 receptors on the discharge of afferent and efferent fibres supplying the rat jejunum
-
567-e209
-
Donovan J., Grundy D. The differential effect of CB1 receptors on the discharge of afferent and efferent fibres supplying the rat jejunum. Neurogastroenterology and Motility 2011, 23. 567-e209.
-
(2011)
Neurogastroenterology and Motility
, vol.23
-
-
Donovan, J.1
Grundy, D.2
-
56
-
-
33845523338
-
Effects of rimonabant (SR141716) on fasting-induced hypothalamic-pituitary-adrenal axis and neuronal activation in lean and obese Zucker rats
-
Doyon C., Denis R.G., Baraboi E.D., Samson P., Lalonde J., Deshaies Y., et al. Effects of rimonabant (SR141716) on fasting-induced hypothalamic-pituitary-adrenal axis and neuronal activation in lean and obese Zucker rats. Diabetes 2006, 55:3403-3410.
-
(2006)
Diabetes
, vol.55
, pp. 3403-3410
-
-
Doyon, C.1
Denis, R.G.2
Baraboi, E.D.3
Samson, P.4
Lalonde, J.5
Deshaies, Y.6
-
57
-
-
51149101671
-
Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats
-
Duncan M., Mouihate A., Mackie K., Keenan C.M., Buckley N.E., Davison J.S., et al. Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats. American Journal of Physiology. Gastrointestinal and Liver Physiology 2008, 295:G78-G87.
-
(2008)
American Journal of Physiology. Gastrointestinal and Liver Physiology
, vol.295
-
-
Duncan, M.1
Mouihate, A.2
Mackie, K.3
Keenan, C.M.4
Buckley, N.E.5
Davison, J.S.6
-
58
-
-
61449252830
-
Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle
-
Eckardt K., Sell H., Taube A., Koenen M., Platzbecker B., Cramer A., et al. Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle. Diabetologia 2009, 52:664-674.
-
(2009)
Diabetologia
, vol.52
, pp. 664-674
-
-
Eckardt, K.1
Sell, H.2
Taube, A.3
Koenen, M.4
Platzbecker, B.5
Cramer, A.6
-
59
-
-
0001850107
-
Structural requirements for cannabinoid activity
-
Edery H., Grunfeld Y., Ben-Zvi Z., Mechoulam R. Structural requirements for cannabinoid activity. Annals of the New York Academy of Sciences 1971, 191:40-53.
-
(1971)
Annals of the New York Academy of Sciences
, vol.191
, pp. 40-53
-
-
Edery, H.1
Grunfeld, Y.2
Ben-Zvi, Z.3
Mechoulam, R.4
-
60
-
-
25844460609
-
Activation of the peripheral endocannabinoid system in human obesity
-
Engeli S., BÖhnke J., Feldpausch M., Gorzelniak K., Janke J., Bátkai S., et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes 2005, 54:2838-2843.
-
(2005)
Diabetes
, vol.54
, pp. 2838-2843
-
-
Engeli, S.1
Böhnke, J.2
Feldpausch, M.3
Gorzelniak, K.4
Janke, J.5
Bátkai, S.6
-
61
-
-
57349088236
-
The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase
-
Esposito I., Proto M.C., Gazzerro P., Laezza C., Miele C., Alberobello A.T., et al. The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase. Molecular Pharmacology 2008, 74:1678-1686.
-
(2008)
Molecular Pharmacology
, vol.74
, pp. 1678-1686
-
-
Esposito, I.1
Proto, M.C.2
Gazzerro, P.3
Laezza, C.4
Miele, C.5
Alberobello, A.T.6
-
63
-
-
77749319413
-
Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis
-
Floreani A., Lazzari R., Macchi V., Porzionato A., Variola A., Colavito D., et al. Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis. Journal of Gastroenterology 2010, 45:68-76.
-
(2010)
Journal of Gastroenterology
, vol.45
, pp. 68-76
-
-
Floreani, A.1
Lazzari, R.2
Macchi, V.3
Porzionato, A.4
Variola, A.5
Colavito, D.6
-
64
-
-
34248532300
-
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in rodents
-
Fong T.M., Guan X.M., Marsh D.J., Shen C.P., Stribling D.S., Rosko K.M., et al. Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in rodents. The Journal of Pharmacology and Experimental Therapeutics 2007, 321:1013-1022.
-
(2007)
The Journal of Pharmacology and Experimental Therapeutics
, vol.321
, pp. 1013-1022
-
-
Fong, T.M.1
Guan, X.M.2
Marsh, D.J.3
Shen, C.P.4
Stribling, D.S.5
Rosko, K.M.6
-
65
-
-
70349128141
-
Cannabinoid-1 receptor inverse agonists: Current understanding of mechanism of action and unanswered questions
-
Fong T.M., Heymsfield S.B. Cannabinoid-1 receptor inverse agonists: Current understanding of mechanism of action and unanswered questions. International Journal of Obesity 2009, 33:947-955.
-
(2009)
International Journal of Obesity
, vol.33
, pp. 947-955
-
-
Fong, T.M.1
Heymsfield, S.B.2
-
66
-
-
0037661996
-
Role of endogenous cannabinoids in synaptic signaling
-
Freund T., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiological Reviews 2003, 83:1017-1066.
-
(2003)
Physiological Reviews
, vol.83
, pp. 1017-1066
-
-
Freund, T.1
Katona, I.2
Piomelli, D.3
-
67
-
-
0035843790
-
Critical role of the endogenous cannabinoid system in mouse pup suckling and growth
-
Fride E., Ginzburg Y., Breuer A., Bisogno T., Di Marzo V., Mechoulam R. Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. European Journal of Pharmacology 2001, 419:207-214.
-
(2001)
European Journal of Pharmacology
, vol.419
, pp. 207-214
-
-
Fride, E.1
Ginzburg, Y.2
Breuer, A.3
Bisogno, T.4
Di Marzo, V.5
Mechoulam, R.6
-
68
-
-
2942716780
-
Modern science versus the stigma of obesity
-
Friedman J.M. Modern science versus the stigma of obesity. Nature Medicine 2004, 10:563-569.
-
(2004)
Nature Medicine
, vol.10
, pp. 563-569
-
-
Friedman, J.M.1
-
70
-
-
0344562864
-
A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene
-
Gadzicki D., Máller-Vahl K., Stuhrmann M. A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene. Molecular and Cellular Probes 1999, 13:321-323.
-
(1999)
Molecular and Cellular Probes
, vol.13
, pp. 321-323
-
-
Gadzicki, D.1
Máller-Vahl, K.2
Stuhrmann, M.3
-
71
-
-
0029094470
-
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
-
Galiègue S., Mary S., Marchand J., Dussossoy D., Carrière D., Carayon P., et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. European Journal of Biochemistry 1995, 232:54-61.
-
(1995)
European Journal of Biochemistry
, vol.232
, pp. 54-61
-
-
Galiègue, S.1
Mary, S.2
Marchand, J.3
Dussossoy, D.4
Carrière, D.5
Carayon, P.6
-
72
-
-
23944487985
-
Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus
-
Gamber K.M., Macarthur H., Westfall T.C. Cannabinoids augment the release of neuropeptide Y in the rat hypothalamus. Neuropharmacology 2005, 49:646-652.
-
(2005)
Neuropharmacology
, vol.49
, pp. 646-652
-
-
Gamber, K.M.1
Macarthur, H.2
Westfall, T.C.3
-
73
-
-
33947489961
-
Isolation, structure, and partial synthesis of an active constituent of hashish
-
Gaoni Y., Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. Journal of the American Chemical Society 1964, 86:1646-1647.
-
(1964)
Journal of the American Chemical Society
, vol.86
, pp. 1646-1647
-
-
Gaoni, Y.1
Mechoulam, R.2
-
74
-
-
31044456243
-
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes
-
Gary-Bobo M., Elachouri G., Scatton B., Le Fur G., Oury-Donat F., Bensaid M. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes. Molecular Pharmacology 2006, 69:471-478.
-
(2006)
Molecular Pharmacology
, vol.69
, pp. 471-478
-
-
Gary-Bobo, M.1
Elachouri, G.2
Scatton, B.3
Le Fur, G.4
Oury-Donat, F.5
Bensaid, M.6
-
75
-
-
33846492418
-
Endocannabinoids in adipocytes during differentiation and their role in glucose uptake
-
Gasperi V., Fezza F., Pasquariello N., Bari M., Oddi S., Agrò A., et al. Endocannabinoids in adipocytes during differentiation and their role in glucose uptake. Cellular and Molecular Life Sciences 2007, 64:219-229.
-
(2007)
Cellular and Molecular Life Sciences
, vol.64
, pp. 219-229
-
-
Gasperi, V.1
Fezza, F.2
Pasquariello, N.3
Bari, M.4
Oddi, S.5
Agrò, A.6
-
76
-
-
58149333713
-
Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes
-
Gaulton K.J., Willer C.J., Li Y., Scott L.J., Conneely K.N., Jackson A.U., et al. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes. Diabetes 2008, 57:3136-3144.
-
(2008)
Diabetes
, vol.57
, pp. 3136-3144
-
-
Gaulton, K.J.1
Willer, C.J.2
Li, Y.3
Scott, L.J.4
Conneely, K.N.5
Jackson, A.U.6
-
77
-
-
0025878961
-
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
-
Gérard C.M., Mollereau C., Vassart G., Parmentier M. Molecular cloning of a human cannabinoid receptor which is also expressed in testis. The Biochemical Journal 1991, 279:129-134.
-
(1991)
The Biochemical Journal
, vol.279
, pp. 129-134
-
-
Gérard, C.M.1
Mollereau, C.2
Vassart, G.3
Parmentier, M.4
-
78
-
-
0016139071
-
Effects of Δ9-THC on food and water intake of deprivation experienced rats
-
Gluck J.P., Ferraro D.P. Effects of Δ9-THC on food and water intake of deprivation experienced rats. Behavioral Biology 1974, 11:395-401.
-
(1974)
Behavioral Biology
, vol.11
, pp. 395-401
-
-
Gluck, J.P.1
Ferraro, D.P.2
-
79
-
-
0036849961
-
A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding
-
GÓmez R., Navarro M., Ferrer B., Trigo J.M., Bilbao A., Del Arco I., et al. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. The Journal of Neuroscience 2002, 22:9612-9617.
-
(2002)
The Journal of Neuroscience
, vol.22
, pp. 9612-9617
-
-
Gómez, R.1
Navarro, M.2
Ferrer, B.3
Trigo, J.M.4
Bilbao, A.5
Del Arco, I.6
-
80
-
-
0017064020
-
Effects of marihuana use on body weight and caloric intake in humans
-
Greenberg I., Kuehnle J., Mendelson J.H., Bernstein J.G. Effects of marihuana use on body weight and caloric intake in humans. Psychopharmacology 1976, 49:79-84.
-
(1976)
Psychopharmacology
, vol.49
, pp. 79-84
-
-
Greenberg, I.1
Kuehnle, J.2
Mendelson, J.H.3
Bernstein, J.G.4
-
82
-
-
42749088228
-
Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!
-
Grimsey N.L., Goodfellow C.E., Scotter E.L., Dowie M.J., Glass M., Graham E.S. Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!. Journal of Neuroscience Methods 2008, 171:78-86.
-
(2008)
Journal of Neuroscience Methods
, vol.171
, pp. 78-86
-
-
Grimsey, N.L.1
Goodfellow, C.E.2
Scotter, E.L.3
Dowie, M.J.4
Glass, M.5
Graham, E.S.6
-
83
-
-
0004294465
-
-
Yale University Press, New Haven, [updated 1997; cited]
-
Grinspoon L., Bakalar J.B. Marihuana, the forbidden medicine 1997, Yale University Press, New Haven, [updated 1997; cited].
-
(1997)
Marihuana, the forbidden medicine
-
-
Grinspoon, L.1
Bakalar, J.B.2
-
84
-
-
0014622071
-
Psychopharmacological activity of the active constituents of hashish and some related cannabinoids
-
Grunfeld Y., Edery H. Psychopharmacological activity of the active constituents of hashish and some related cannabinoids. Psychopharmacology 1969, 14:200-210.
-
(1969)
Psychopharmacology
, vol.14
, pp. 200-210
-
-
Grunfeld, Y.1
Edery, H.2
-
85
-
-
0043162058
-
Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain
-
Hanus L., Avraham Y., Ben-Shushan D., Zolotarev O., Berry E.M., Mechoulam R. Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain. Brain Research 2003, 983:144-151.
-
(2003)
Brain Research
, vol.983
, pp. 144-151
-
-
Hanus, L.1
Avraham, Y.2
Ben-Shushan, D.3
Zolotarev, O.4
Berry, E.M.5
Mechoulam, R.6
-
86
-
-
12944263838
-
HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor
-
Hanuš L., Breuer A., Tchilibon S., Shiloah S., Goldenberg D., Horowitz M., et al. HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor. Proceedings of the National Academy of Sciences 1999, 96:14228-14233.
-
(1999)
Proceedings of the National Academy of Sciences
, vol.96
, pp. 14228-14233
-
-
Hanuš, L.1
Breuer, A.2
Tchilibon, S.3
Shiloah, S.4
Goldenberg, D.5
Horowitz, M.6
-
87
-
-
0034737597
-
Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice
-
Hao S., Avraham Y., Mechoulam R., Berry E.M. Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice. European Journal of Pharmacology 2000, 392:147-156.
-
(2000)
European Journal of Pharmacology
, vol.392
, pp. 147-156
-
-
Hao, S.1
Avraham, Y.2
Mechoulam, R.3
Berry, E.M.4
-
88
-
-
0018194701
-
Evidence for the existence of specific cannabinoid binding sites
-
Harris L.S., Carchman R.A., Martin B.R. Evidence for the existence of specific cannabinoid binding sites. Life Sciences 1978, 22:1131-1137.
-
(1978)
Life Sciences
, vol.22
, pp. 1131-1137
-
-
Harris, L.S.1
Carchman, R.A.2
Martin, B.R.3
-
90
-
-
0025954862
-
Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study
-
Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. The Journal of Neuroscience 1991, 11:563-583.
-
(1991)
The Journal of Neuroscience
, vol.11
, pp. 563-583
-
-
Herkenham, M.1
Lynn, A.B.2
Johnson, M.R.3
Melvin, L.S.4
de Costa, B.R.5
Rice, K.C.6
-
91
-
-
34548417986
-
CB1 receptor antagonist AVE1625 affects primarily metabolic parameters independently of reduced food intake in Wistar rats
-
Herling A.W., Gossel M., Haschke G., Stengelin S., Kuhlmann J., Máller G., et al. CB1 receptor antagonist AVE1625 affects primarily metabolic parameters independently of reduced food intake in Wistar rats. American Journal of Physiology. Endocrinology and Metabolism 2007, 293:E826-E832.
-
(2007)
American Journal of Physiology. Endocrinology and Metabolism
, vol.293
-
-
Herling, A.W.1
Gossel, M.2
Haschke, G.3
Stengelin, S.4
Kuhlmann, J.5
Máller, G.6
-
92
-
-
42449164329
-
Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed Wistar rats
-
Herling A.W., Kilp S., Elvert R., Haschke G., Kramer W. Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed Wistar rats. Endocrinology 2008, 149:2557-2566.
-
(2008)
Endocrinology
, vol.149
, pp. 2557-2566
-
-
Herling, A.W.1
Kilp, S.2
Elvert, R.3
Haschke, G.4
Kramer, W.5
-
93
-
-
12344318287
-
Coexpression of the cannabinoid receptor type 1 with the corticotropin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain
-
Hermann H., Lutz B. Coexpression of the cannabinoid receptor type 1 with the corticotropin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain. Neuroscience Letters 2005, 375:13-18.
-
(2005)
Neuroscience Letters
, vol.375
, pp. 13-18
-
-
Hermann, H.1
Lutz, B.2
-
94
-
-
35648944276
-
GPR55 and the vascular receptors for cannabinoids
-
Hiley C.R., Kaup S.S. GPR55 and the vascular receptors for cannabinoids. British Journal of Pharmacology 2007, 152:559-561.
-
(2007)
British Journal of Pharmacology
, vol.152
, pp. 559-561
-
-
Hiley, C.R.1
Kaup, S.S.2
-
96
-
-
77649260031
-
Effect of rimonabant on glycemic control in insulin-treated type 2 diabetes: The ARPEGGIO trial
-
for the ARPEGGIO Study Group
-
Hollander P.A., Amod A., Litwak L.E., Chaudhari U., for the ARPEGGIO Study Group Effect of rimonabant on glycemic control in insulin-treated type 2 diabetes: The ARPEGGIO trial. Diabetes Care 2010, 33:605-607.
-
(2010)
Diabetes Care
, vol.33
, pp. 605-607
-
-
Hollander, P.A.1
Amod, A.2
Litwak, L.E.3
Chaudhari, U.4
-
97
-
-
0015207811
-
Marihuana in man: Three years later
-
Hollister L.E. Marihuana in man: Three years later. Science 1971, 172:21-29.
-
(1971)
Science
, vol.172
, pp. 21-29
-
-
Hollister, L.E.1
-
98
-
-
35648985647
-
PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats
-
Horswill J.G., Bali U., Shaaban S., Keily J.F., Jeevaratnam P., Babbs A.J., et al. PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats. British Journal of Pharmacology 2007, 152:805-814.
-
(2007)
British Journal of Pharmacology
, vol.152
, pp. 805-814
-
-
Horswill, J.G.1
Bali, U.2
Shaaban, S.3
Keily, J.F.4
Jeevaratnam, P.5
Babbs, A.J.6
-
99
-
-
0021722983
-
Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes
-
Howlett A.C., Fleming R.M. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Molecular Pharmacology 1984, 26:532-538.
-
(1984)
Molecular Pharmacology
, vol.26
, pp. 532-538
-
-
Howlett, A.C.1
Fleming, R.M.2
-
100
-
-
0023914862
-
Nonclassical cannabinoid analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model
-
Howlett A.C., Johnson M.R., Melvin L.S., Milne G.M. Nonclassical cannabinoid analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model. Molecular Pharmacology 1988, 33:297-302.
-
(1988)
Molecular Pharmacology
, vol.33
, pp. 297-302
-
-
Howlett, A.C.1
Johnson, M.R.2
Melvin, L.S.3
Milne, G.M.4
-
101
-
-
34247895688
-
Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: Implications for cannabinoid actions on food intake and cognitive arousal
-
Huang H., Acuna-Goycolea C., Li Y., Cheng H.M., Obrietan K., van den Pol A.N. Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: Implications for cannabinoid actions on food intake and cognitive arousal. The Journal of Neuroscience 2007, 27:4870-4881.
-
(2007)
The Journal of Neuroscience
, vol.27
, pp. 4870-4881
-
-
Huang, H.1
Acuna-Goycolea, C.2
Li, Y.3
Cheng, H.M.4
Obrietan, K.5
van den Pol, A.N.6
-
102
-
-
0034740564
-
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation
-
Izzo A.A., Fezza F., Capasso R., Bisogno T., Pinto L., Iuvone T., et al. Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation. British Journal of Pharmacology 2001, 134:563-570.
-
(2001)
British Journal of Pharmacology
, vol.134
, pp. 563-570
-
-
Izzo, A.A.1
Fezza, F.2
Capasso, R.3
Bisogno, T.4
Pinto, L.5
Iuvone, T.6
-
103
-
-
2442651556
-
Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motif
-
Jagerovic N., Hernandez-Folgado L., Alkorta I., Goya P., Navarro M., Serrano A., et al. Discovery of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole, a novel in vivo cannabinoid antagonist containing a 1,2,4-triazole motif. Journal of Medicinal Chemistry 2004, 47:2939-2942.
-
(2004)
Journal of Medicinal Chemistry
, vol.47
, pp. 2939-2942
-
-
Jagerovic, N.1
Hernandez-Folgado, L.2
Alkorta, I.3
Goya, P.4
Navarro, M.5
Serrano, A.6
-
104
-
-
0035185205
-
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats
-
Jamshidi N., Taylor D.A. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. British Journal of Pharmacology 2001, 134:1151-1154.
-
(2001)
British Journal of Pharmacology
, vol.134
, pp. 1151-1154
-
-
Jamshidi, N.1
Taylor, D.A.2
-
105
-
-
0038845604
-
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
-
Járai Z., Wagner J.A., Varga K., Lake K.D., Compton D.R., Martin B.R., et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proceedings of the National Academy of Sciences 1999, 96:14136-14141.
-
(1999)
Proceedings of the National Academy of Sciences
, vol.96
, pp. 14136-14141
-
-
Járai, Z.1
Wagner, J.A.2
Varga, K.3
Lake, K.D.4
Compton, D.R.5
Martin, B.R.6
-
106
-
-
24644500204
-
The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance
-
Jbilo O., Ravinet-Trillou C., Arnone M., Buisson I., Bribes E., Péleraux A., et al. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. The FASEB Journal 2005, 19:1567-1569.
-
(2005)
The FASEB Journal
, vol.19
, pp. 1567-1569
-
-
Jbilo, O.1
Ravinet-Trillou, C.2
Arnone, M.3
Buisson, I.4
Bribes, E.5
Péleraux, A.6
-
107
-
-
58249105329
-
Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2
-
Jelsing J., Galzin A.M., Guillot E., Pruniaux M.P., Larsen P.J., Vrang N. Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2. Brain Research Bulletin 2009, 78:202-210.
-
(2009)
Brain Research Bulletin
, vol.78
, pp. 202-210
-
-
Jelsing, J.1
Galzin, A.M.2
Guillot, E.3
Pruniaux, M.P.4
Larsen, P.J.5
Vrang, N.6
-
108
-
-
38649114788
-
Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver
-
Jeong W.I., Osei-Hyiaman D., Park O., Liu J., Bátkai S., Mukhopadhyay P., et al. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metabolism 2008, 7:227-235.
-
(2008)
Cell Metabolism
, vol.7
, pp. 227-235
-
-
Jeong, W.I.1
Osei-Hyiaman, D.2
Park, O.3
Liu, J.4
Bátkai, S.5
Mukhopadhyay, P.6
-
109
-
-
0019604103
-
Selective and potent analgetics derived from cannabinoids
-
Johnson M.R., Melvin L.S., Althuis T.H., Bindra J.S., Harbert C.A., Milne G.M., et al. Selective and potent analgetics derived from cannabinoids. The Journal of Clinical Pharmacology 1981, 21:271S-282S.
-
(1981)
The Journal of Clinical Pharmacology
, vol.21
-
-
Johnson, M.R.1
Melvin, L.S.2
Althuis, T.H.3
Bindra, J.S.4
Harbert, C.A.5
Milne, G.M.6
-
110
-
-
57049102251
-
End of the line for cannabinoid receptor 1 as an anti-obesity target?
-
Jones D. End of the line for cannabinoid receptor 1 as an anti-obesity target?. Nature Reviews. Drug Discovery 2008, 7:961-962.
-
(2008)
Nature Reviews. Drug Discovery
, vol.7
, pp. 961-962
-
-
Jones, D.1
-
111
-
-
77951184370
-
CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice
-
Jourdan T., Djaouti L., Demizieux L., Gresti J., Vergès B., Degrace P. CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice. Diabetes 2010, 59:926-934.
-
(2010)
Diabetes
, vol.59
, pp. 926-934
-
-
Jourdan, T.1
Djaouti, L.2
Demizieux, L.3
Gresti, J.4
Vergès, B.5
Degrace, P.6
-
112
-
-
29544435299
-
Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell
-
Juan-PicÓ P., Fuentes E., Javier Bermúdez-Silva F., Javier Díaz-Molina F., Ripoll C., Rodríguez de Fonseca F., et al. Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell. Cell Calcium 2006, 39:155-162.
-
(2006)
Cell Calcium
, vol.39
, pp. 155-162
-
-
Juan-Picó, P.1
Fuentes, E.2
Javier Bermúdez-Silva, F.3
Javier Díaz-Molina, F.4
Ripoll, C.5
Rodríguez de Fonseca, F.6
-
113
-
-
70350376735
-
Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands
-
Kapur A., Zhao P., Sharir H., Bai Y., Caron M.G., Barak L.S., et al. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. The Journal of Biological Chemistry 2009, 284:29817-29827.
-
(2009)
The Journal of Biological Chemistry
, vol.284
, pp. 29817-29827
-
-
Kapur, A.1
Zhao, P.2
Sharir, H.3
Bai, Y.4
Caron, M.G.5
Barak, L.S.6
-
114
-
-
0030767295
-
CDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase
-
Karlsson M., Contreras J.A., Hellman U., Tornqvist H., Holm C. cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. The Journal of Biological Chemistry 1997, 272:27218-27223.
-
(1997)
The Journal of Biological Chemistry
, vol.272
, pp. 27218-27223
-
-
Karlsson, M.1
Contreras, J.A.2
Hellman, U.3
Tornqvist, H.4
Holm, C.5
-
115
-
-
0001048154
-
Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine
-
Katayama K., Ueda N., Kurahashi Y., Suzuki H., Yamamoto S., Kato I. Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine. Biochimica et Biophysica Acta 1997, 1347:212-218.
-
(1997)
Biochimica et Biophysica Acta
, vol.1347
, pp. 212-218
-
-
Katayama, K.1
Ueda, N.2
Kurahashi, Y.3
Suzuki, H.4
Yamamoto, S.5
Kato, I.6
-
116
-
-
79953216705
-
Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells
-
Kim W., Doyle M.E., Liu Z., Lao Q., Shin Y.K., Carlson O.D., et al. Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells. Diabetes 2011, 60:1198-1209.
-
(2011)
Diabetes
, vol.60
, pp. 1198-1209
-
-
Kim, W.1
Doyle, M.E.2
Liu, Z.3
Lao, Q.4
Shin, Y.K.5
Carlson, O.D.6
-
117
-
-
77952290508
-
A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes
-
Kipnes M.S., Hollander P., Fujioka K., Gantz I., Seck T., Erondu N., et al. A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes. Diabetes, Obesity & Metabolism 2010, 12:517-531.
-
(2010)
Diabetes, Obesity & Metabolism
, vol.12
, pp. 517-531
-
-
Kipnes, M.S.1
Hollander, P.2
Fujioka, K.3
Gantz, I.4
Seck, T.5
Erondu, N.6
-
118
-
-
0035984946
-
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: Stimulation of eating by 2-arachidonoyl glycerol
-
Kirkham T.C., Williams C.M., Fezza F., Marzo V.D. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: Stimulation of eating by 2-arachidonoyl glycerol. British Journal of Pharmacology 2002, 136:550-557.
-
(2002)
British Journal of Pharmacology
, vol.136
, pp. 550-557
-
-
Kirkham, T.C.1
Williams, C.M.2
Fezza, F.3
Marzo, V.D.4
-
119
-
-
45549092924
-
The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system
-
Kola B., Farkas I., Christ-Crain M., Wittmann G., Lolli F., Amin F., et al. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS One 2008, 3:e1797.
-
(2008)
PLoS One
, vol.3
-
-
Kola, B.1
Farkas, I.2
Christ-Crain, M.3
Wittmann, G.4
Lolli, F.5
Amin, F.6
-
120
-
-
21644453934
-
Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase
-
Kola B., Hubina E., Tucci S.A., Kirkham T.C., Garcia E.A., Mitchell S.E., et al. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. The Journal of Biological Chemistry 2005, 280:25196-25201.
-
(2005)
The Journal of Biological Chemistry
, vol.280
, pp. 25196-25201
-
-
Kola, B.1
Hubina, E.2
Tucci, S.A.3
Kirkham, T.C.4
Garcia, E.A.5
Mitchell, S.E.6
-
121
-
-
0037118910
-
Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB1 receptors
-
Landi M., Croci T., Rinaldi-Carmona M., Maffrand J.P., Le Fur G., Manara L. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB1 receptors. European Journal of Pharmacology 2002, 450:77-83.
-
(2002)
European Journal of Pharmacology
, vol.450
, pp. 77-83
-
-
Landi, M.1
Croci, T.2
Rinaldi-Carmona, M.3
Maffrand, J.P.4
Le Fur, G.5
Manara, L.6
-
122
-
-
0033555839
-
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
-
Ledent C., Valverde O., Cossu G., Petitet F., Aubert J.F., Beslot F., et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 1999, 283:401-404.
-
(1999)
Science
, vol.283
, pp. 401-404
-
-
Ledent, C.1
Valverde, O.2
Cossu, G.3
Petitet, F.4
Aubert, J.F.5
Beslot, F.6
-
123
-
-
59349103952
-
Involvement of cannabinoid CB1- and CB2-receptors in the modulation of exocrine pancreatic secretion
-
Linari G., Agostini S., Amadoro G., Ciotti M.T., Florenzano F., Improta G., et al. Involvement of cannabinoid CB1- and CB2-receptors in the modulation of exocrine pancreatic secretion. Pharmacological Research 2009, 59:207-214.
-
(2009)
Pharmacological Research
, vol.59
, pp. 207-214
-
-
Linari, G.1
Agostini, S.2
Amadoro, G.3
Ciotti, M.T.4
Florenzano, F.5
Improta, G.6
-
124
-
-
77449118145
-
Regulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells
-
Lipina C., Stretton C., Hastings S., Hundal J.S., Mackie K., Irving A.J., et al. Regulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells. Diabetes 2010, 59:375-385.
-
(2010)
Diabetes
, vol.59
, pp. 375-385
-
-
Lipina, C.1
Stretton, C.2
Hastings, S.3
Hundal, J.S.4
Mackie, K.5
Irving, A.J.6
-
125
-
-
13244249625
-
Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice
-
Liu Y.L., Connoley I.P., Wilson C.A., Stock M.J. Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice. International Journal of Obesity and Related Metabolic Disorders 2004, 29:183-187.
-
(2004)
International Journal of Obesity and Related Metabolic Disorders
, vol.29
, pp. 183-187
-
-
Liu, Y.L.1
Connoley, I.P.2
Wilson, C.A.3
Stock, M.J.4
-
126
-
-
33748608009
-
A biosynthetic pathway for anandamide
-
Liu J., Wang L., Harvey-White J., Osei-Hyiaman D., Razdan R., Gong Q., et al. A biosynthetic pathway for anandamide. Proceedings of the National Academy of Sciences 2006, 103:13345-13350.
-
(2006)
Proceedings of the National Academy of Sciences
, vol.103
, pp. 13345-13350
-
-
Liu, J.1
Wang, L.2
Harvey-White, J.3
Osei-Hyiaman, D.4
Razdan, R.5
Gong, Q.6
-
127
-
-
57749087828
-
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
-
Long J.Z., Li W., Booker L., Burston J.J., Kinsey S.G., Schlosburg J.E., et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nature Chemical Biology 2009, 5:37-44.
-
(2009)
Nature Chemical Biology
, vol.5
, pp. 37-44
-
-
Long, J.Z.1
Li, W.2
Booker, L.3
Burston, J.J.4
Kinsey, S.G.5
Schlosburg, J.E.6
-
128
-
-
35348864420
-
Endocannabinoid hedonic hotspot for sensory pleasure: Anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward
-
Mahler S.V., Smith K.S., Berridge K.C. Endocannabinoid hedonic hotspot for sensory pleasure: Anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward. Neuropsychopharmacology 2007, 32:2267-2278.
-
(2007)
Neuropsychopharmacology
, vol.32
, pp. 2267-2278
-
-
Mahler, S.V.1
Smith, K.S.2
Berridge, K.C.3
-
129
-
-
0015236718
-
Inhibition of normal growth by chronic administration of Δ-9-tetrahydrocannabinol
-
Manning F.J., McDonough J.H., Elsmore T.F., Saller C., Sodetz F.J. Inhibition of normal growth by chronic administration of Δ-9-tetrahydrocannabinol. Science 1971, 174:424-426.
-
(1971)
Science
, vol.174
, pp. 424-426
-
-
Manning, F.J.1
McDonough, J.H.2
Elsmore, T.F.3
Saller, C.4
Sodetz, F.J.5
-
130
-
-
0033452718
-
Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain
-
Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. The European Journal of Neuroscience 1999, 11:4213-4225.
-
(1999)
The European Journal of Neuroscience
, vol.11
, pp. 4213-4225
-
-
Marsicano, G.1
Lutz, B.2
-
131
-
-
0022448676
-
Cellular effects of cannabinoids
-
Martin B.R. Cellular effects of cannabinoids. Pharmacological Reviews 1986, 38:45-74.
-
(1986)
Pharmacological Reviews
, vol.38
, pp. 45-74
-
-
Martin, B.R.1
-
132
-
-
0019827653
-
Behavioral comparisons of the stereoisomers of tetrahydrocannabinols
-
Martin B.R., Balster R.L., Razdan R.K., Harris L.S., Dewey W.L. Behavioral comparisons of the stereoisomers of tetrahydrocannabinols. Life Sciences 1981, 29:565-574.
-
(1981)
Life Sciences
, vol.29
, pp. 565-574
-
-
Martin, B.R.1
Balster, R.L.2
Razdan, R.K.3
Harris, L.S.4
Dewey, W.L.5
-
133
-
-
33847403181
-
Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1
-
Martini L., Waldhoer M., Pusch M., Kharazia V., Fong J., Lee J.H., et al. Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1. The FASEB Journal 2007, 21:802-811.
-
(2007)
The FASEB Journal
, vol.21
, pp. 802-811
-
-
Martini, L.1
Waldhoer, M.2
Pusch, M.3
Kharazia, V.4
Fong, J.5
Lee, J.H.6
-
134
-
-
77951777420
-
Alterations in the hippocampal endocannabinoid system in diet-induced obese mice
-
Massa F., Mancini G., Schmidt H., Steindel F., Mackie K., Angioni C., et al. Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. The Journal of Neuroscience 2010, 30:6273-6281.
-
(2010)
The Journal of Neuroscience
, vol.30
, pp. 6273-6281
-
-
Massa, F.1
Mancini, G.2
Schmidt, H.3
Steindel, F.4
Mackie, K.5
Angioni, C.6
-
135
-
-
33747644061
-
Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia
-
Matias I., Gonthier M.P., Orlando P., Martiadis V., De Petrocellis L., Cervino C., et al. Regulation, function, and dysregulation of endocannabinoids in models of adipose and β-pancreatic cells and in obesity and hyperglycemia. The Journal of Clinical Endocrinology and Metabolism 2006, 91:3171-3180.
-
(2006)
The Journal of Clinical Endocrinology and Metabolism
, vol.91
, pp. 3171-3180
-
-
Matias, I.1
Gonthier, M.P.2
Orlando, P.3
Martiadis, V.4
De Petrocellis, L.5
Cervino, C.6
-
136
-
-
0037123850
-
Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain
-
Mato S., Pazos A., Valdizán E.M. Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain. European Journal of Pharmacology 2002, 443:43-46.
-
(2002)
European Journal of Pharmacology
, vol.443
, pp. 43-46
-
-
Mato, S.1
Pazos, A.2
Valdizán, E.M.3
-
137
-
-
0025325535
-
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
-
Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
-
(1990)
Nature
, vol.346
, pp. 561-564
-
-
Matsuda, L.A.1
Lolait, S.J.2
Brownstein, M.J.3
Young, A.C.4
Bonner, T.I.5
-
138
-
-
0028123111
-
Cannabinoids and appetite stimulation
-
Mattes R.D., Engelman K., Shaw L.M., Elsohly M.A. Cannabinoids and appetite stimulation. Pharmacology, Biochemistry, and Behavior 1994, 49:187-195.
-
(1994)
Pharmacology, Biochemistry, and Behavior
, vol.49
, pp. 187-195
-
-
Mattes, R.D.1
Engelman, K.2
Shaw, L.M.3
Elsohly, M.A.4
-
139
-
-
0014933381
-
Marihuana chemistry
-
Mechoulam R. Marihuana chemistry. Science 1970, 168:1159-1166.
-
(1970)
Science
, vol.168
, pp. 1159-1166
-
-
Mechoulam, R.1
-
140
-
-
0029012014
-
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
-
Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology 1995, 50:83-90.
-
(1995)
Biochemical Pharmacology
, vol.50
, pp. 83-90
-
-
Mechoulam, R.1
Ben-Shabat, S.2
Hanus, L.3
Ligumsky, M.4
Kaminski, N.E.5
Schatz, A.R.6
-
142
-
-
0033660254
-
A historical overview of chemical research on cannabinoids
-
Mechoulam R., Hanuš L. A historical overview of chemical research on cannabinoids. Chemistry and Physics of Lipids 2000, 108:1-13.
-
(2000)
Chemistry and Physics of Lipids
, vol.108
, pp. 1-13
-
-
Mechoulam, R.1
Hanuš, L.2
-
143
-
-
0015432732
-
Synthesis and biological activity of five tetrahydrocannabinol metabolites
-
Mechoulam R., Varconi H., Ben-Zvi Z., Edery H., Grunfeld Y. Synthesis and biological activity of five tetrahydrocannabinol metabolites. Journal of the American Chemical Society 1972, 94:7930-7931.
-
(1972)
Journal of the American Chemical Society
, vol.94
, pp. 7930-7931
-
-
Mechoulam, R.1
Varconi, H.2
Ben-Zvi, Z.3
Edery, H.4
Grunfeld, Y.5
-
144
-
-
1242337340
-
Cannabinoid agonist, CP 55,940, facilitates intake of palatable foods when injected into the hindbrain
-
Miller C.C., Murray T.F., Freeman K.G., Edwards G.L. Cannabinoid agonist, CP 55,940, facilitates intake of palatable foods when injected into the hindbrain. Physiology & Behavior 2004, 80:611-616.
-
(2004)
Physiology & Behavior
, vol.80
, pp. 611-616
-
-
Miller, C.C.1
Murray, T.F.2
Freeman, K.G.3
Edwards, G.L.4
-
145
-
-
1842484296
-
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus
-
Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-574.
-
(2004)
Nature
, vol.428
, pp. 569-574
-
-
Minokoshi, Y.1
Alquier, T.2
Furukawa, N.3
Kim, Y.B.4
Lee, A.5
Xue, B.6
-
146
-
-
77957008369
-
Effect of the cannabinoid receptor-1 antagonist rimonabant on lipolysis in rats
-
Mølhøj S., Hansen H.S., Schweiger M., Zimmermann R., Johansen T., MalmlÖf K. Effect of the cannabinoid receptor-1 antagonist rimonabant on lipolysis in rats. European Journal of Pharmacology 2010, 646:38-45.
-
(2010)
European Journal of Pharmacology
, vol.646
, pp. 38-45
-
-
Mølhøj, S.1
Hansen, H.S.2
Schweiger, M.3
Zimmermann, R.4
Johansen, T.5
Malmlöf, K.6
-
147
-
-
33847043132
-
CB2 cannabinoid receptors promote mouse neural stem cell proliferation
-
Molina-Holgado F., Rubio-Araiz A., García-Ovejero D., Williams R.J., Moore J.D., Arévalo-Martín á., et al. CB2 cannabinoid receptors promote mouse neural stem cell proliferation. The European Journal of Neuroscience 2007, 25:629-634.
-
(2007)
The European Journal of Neuroscience
, vol.25
, pp. 629-634
-
-
Molina-Holgado, F.1
Rubio-Araiz, A.2
García-Ovejero, D.3
Williams, R.J.4
Moore, J.D.5
Arévalo-Martín, Á.6
-
148
-
-
35649000942
-
Genetic dissection of behavioural and autonomic effects of Δ9-tetrahydrocannabinol in mice
-
Monory K., Blaudzun H., Massa F., Kaiser N., Lemberger T., Schátz G., et al. Genetic dissection of behavioural and autonomic effects of Δ9-tetrahydrocannabinol in mice. PLoS Biology 2007, 5:e269.
-
(2007)
PLoS Biology
, vol.5
-
-
Monory, K.1
Blaudzun, H.2
Massa, F.3
Kaiser, N.4
Lemberger, T.5
Schátz, G.6
-
149
-
-
19344363569
-
Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa
-
Monteleone P., Matias I., Martiadis V., De Petrocellis L., Maj M., Di Marzo V. Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa. Neuropsychopharmacology 2005, 30:1216-1221.
-
(2005)
Neuropsychopharmacology
, vol.30
, pp. 1216-1221
-
-
Monteleone, P.1
Matias, I.2
Martiadis, V.3
De Petrocellis, L.4
Maj, M.5
Di Marzo, V.6
-
150
-
-
48749100198
-
The CB1 endocannabinoid system modulates adipocyte insulin sensitivity
-
Motaghedi R., McGraw T.E. The CB1 endocannabinoid system modulates adipocyte insulin sensitivity. Obesity 2008, 16:1727-1734.
-
(2008)
Obesity
, vol.16
, pp. 1727-1734
-
-
Motaghedi, R.1
McGraw, T.E.2
-
151
-
-
77955153069
-
The endocannabinoid system links gut microbiota to adipogenesis
-
Muccioli G.G., Naslain D., Backhed F., Reigstad C.S., Lambert D.M., Delzenne N.M., et al. The endocannabinoid system links gut microbiota to adipogenesis. Molecular Systems Biology 2010, 6:392.
-
(2010)
Molecular Systems Biology
, vol.6
, pp. 392
-
-
Muccioli, G.G.1
Naslain, D.2
Backhed, F.3
Reigstad, C.S.4
Lambert, D.M.5
Delzenne, N.M.6
-
152
-
-
77953486365
-
Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor
-
Mukhopadhyay B., Liu J., Osei-Hyiaman D., Godlewski G., Mukhopadhyay P., Wang L., et al. Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor. The Journal of Biological Chemistry 2010, 285:19002-19011.
-
(2010)
The Journal of Biological Chemistry
, vol.285
, pp. 19002-19011
-
-
Mukhopadhyay, B.1
Liu, J.2
Osei-Hyiaman, D.3
Godlewski, G.4
Mukhopadhyay, P.5
Wang, L.6
-
153
-
-
0027515373
-
Molecular characterization of a peripheral receptor for cannabinoids
-
Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
-
(1993)
Nature
, vol.365
, pp. 61-65
-
-
Munro, S.1
Thomas, K.L.2
Abu-Shaar, M.3
-
154
-
-
37349059404
-
Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet β-cells via CB1 receptors
-
Nakata M., Yada T. Cannabinoids inhibit insulin secretion and cytosolic Ca2+ oscillation in islet β-cells via CB1 receptors. Regulatory Peptides 2008, 145:49-53.
-
(2008)
Regulatory Peptides
, vol.145
, pp. 49-53
-
-
Nakata, M.1
Yada, T.2
-
155
-
-
80053296564
-
Cloning and pharmacological characterization of the dog cannabinoid CB2 receptor
-
Ndong C., O'Donnell D., Ahmad S., Groblewski T. Cloning and pharmacological characterization of the dog cannabinoid CB2 receptor. European Journal of Pharmacology 2011, 669:24-31.
-
(2011)
European Journal of Pharmacology
, vol.669
, pp. 24-31
-
-
Ndong, C.1
O'Donnell, D.2
Ahmad, S.3
Groblewski, T.4
-
156
-
-
41649090426
-
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease
-
Nissen S.E., Nicholls S.J., Wolski K., Rodés-Cabau J., Cannon C.P., Deanfield J.E., et al. Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease. JAMA: The Journal of the American Medical Association 2008, 299:1547-1560.
-
(2008)
JAMA: The Journal of the American Medical Association
, vol.299
, pp. 1547-1560
-
-
Nissen, S.E.1
Nicholls, S.J.2
Wolski, K.3
Rodés-Cabau, J.4
Cannon, C.P.5
Deanfield, J.E.6
-
157
-
-
58149128824
-
Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats
-
Nogueiras R., Veyrat-Durebex C., Suchanek P.M., Klein M., TschÖp J., Caldwell C., et al. Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats. Diabetes 2008, 57:2977-2991.
-
(2008)
Diabetes
, vol.57
, pp. 2977-2991
-
-
Nogueiras, R.1
Veyrat-Durebex, C.2
Suchanek, P.M.3
Klein, M.4
Tschöp, J.5
Caldwell, C.6
-
158
-
-
81055156684
-
Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation
-
Nomura D.K., Morrison B.E., Blankman J.L., Long J.Z., Kinsey S.G., Marcondes M.C., et al. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 2011, 334:809-813.
-
(2011)
Science
, vol.334
, pp. 809-813
-
-
Nomura, D.K.1
Morrison, B.E.2
Blankman, J.L.3
Long, J.Z.4
Kinsey, S.G.5
Marcondes, M.C.6
-
159
-
-
58149485817
-
Human obesity as a heritable disorder of the central control of energy balance
-
O'Rahilly S., Farooqi I.S. Human obesity as a heritable disorder of the central control of energy balance. International Journal of Obesity 2008, 32:S55-S61.
-
(2008)
International Journal of Obesity
, vol.32
-
-
O'Rahilly, S.1
Farooqi, I.S.2
-
160
-
-
34548591720
-
Identification of GPR55 as a lysophosphatidylinositol receptor
-
Oka S., Nakajima K., Yamashita A., Kishimoto S., Sugiura T. Identification of GPR55 as a lysophosphatidylinositol receptor. Biochemical and Biophysical Research Communications 2007, 362:928-934.
-
(2007)
Biochemical and Biophysical Research Communications
, vol.362
, pp. 928-934
-
-
Oka, S.1
Nakajima, K.2
Yamashita, A.3
Kishimoto, S.4
Sugiura, T.5
-
161
-
-
1242294480
-
Molecular characterization of a phospholipase D generating anandamide and its congeners
-
Okamoto Y., Morishita J., Tsuboi K., Tonai T., Ueda N. Molecular characterization of a phospholipase D generating anandamide and its congeners. The Journal of Biological Chemistry 2004, 279:5298-5305.
-
(2004)
The Journal of Biological Chemistry
, vol.279
, pp. 5298-5305
-
-
Okamoto, Y.1
Morishita, J.2
Tsuboi, K.3
Tonai, T.4
Ueda, N.5
-
162
-
-
20944436157
-
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
-
Osei-Hyiaman D., DePetrillo M., Pacher P., Liu J., Radaeva S., Bátkai S., et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. The Journal of Clinical Investigation 2005, 115:1298-1305.
-
(2005)
The Journal of Clinical Investigation
, vol.115
, pp. 1298-1305
-
-
Osei-Hyiaman, D.1
DePetrillo, M.2
Pacher, P.3
Liu, J.4
Radaeva, S.5
Bátkai, S.6
-
163
-
-
51349153318
-
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
-
Osei-Hyiaman D., Liu J., Zhou L., Godlewski G., Harvey-White J., Jeong W.I., et al. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. The Journal of Clinical Investigation 2008, 118:3160-3169.
-
(2008)
The Journal of Clinical Investigation
, vol.118
, pp. 3160-3169
-
-
Osei-Hyiaman, D.1
Liu, J.2
Zhou, L.3
Godlewski, G.4
Harvey-White, J.5
Jeong, W.I.6
-
164
-
-
0027196816
-
Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: A quantitative autoradiographic study
-
Oviedo A., Glowa J., Herkenham M. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: A quantitative autoradiographic study. Brain Research 1993, 616:293-302.
-
(1993)
Brain Research
, vol.616
, pp. 293-302
-
-
Oviedo, A.1
Glowa, J.2
Herkenham, M.3
-
165
-
-
33748703859
-
The endocannabinoid system as an emerging target of pharmacotherapy
-
Pacher P., Btkai S., Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacological Reviews 2006, 58:389-462.
-
(2006)
Pharmacological Reviews
, vol.58
, pp. 389-462
-
-
Pacher, P.1
Btkai, S.2
Kunos, G.3
-
166
-
-
80053276336
-
The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice
-
Pang Z., Wu N.N., Zhao W., Chain D.C., Schaffer E., Zhang X., et al. The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice. Obesity 2011, 19:1923-1934.
-
(2011)
Obesity
, vol.19
, pp. 1923-1934
-
-
Pang, Z.1
Wu, N.N.2
Zhao, W.3
Chain, D.C.4
Schaffer, E.5
Zhang, X.6
-
167
-
-
82855164046
-
Cannabinoid receptor type I modulates alcohol-induced liver fibrosis
-
Patsenker E., Stoll M., Millonig G., Agaimy A., Wissniowski T., Schneider V., et al. Cannabinoid receptor type I modulates alcohol-induced liver fibrosis. Molecular Medicine 2011, 17:1285-1294.
-
(2011)
Molecular Medicine
, vol.17
, pp. 1285-1294
-
-
Patsenker, E.1
Stoll, M.2
Millonig, G.3
Agaimy, A.4
Wissniowski, T.5
Schneider, V.6
-
168
-
-
33746110406
-
Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole-LH 21
-
Pavon F.J., Bilbao A., Hernández-Folgado L., Cippitelli A., Jagerovic N., Abellán G., et al. Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole-LH 21. Neuropharmacology 2006, 51:358-366.
-
(2006)
Neuropharmacology
, vol.51
, pp. 358-366
-
-
Pavon, F.J.1
Bilbao, A.2
Hernández-Folgado, L.3
Cippitelli, A.4
Jagerovic, N.5
Abellán, G.6
-
169
-
-
0035010955
-
Cannabinoids and the gastrointestinal tract
-
Pertwee R.G. Cannabinoids and the gastrointestinal tract. Gut 2001, 48:859-867.
-
(2001)
Gut
, vol.48
, pp. 859-867
-
-
Pertwee, R.G.1
-
170
-
-
73349119690
-
Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes
-
Perwitz N., Wenzel J., Wagner I., Báning J., Drenckhan M., Zarse K., et al. Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes. Diabetes, Obesity and Metabolism 2010, 12:158-166.
-
(2010)
Diabetes, Obesity and Metabolism
, vol.12
, pp. 158-166
-
-
Perwitz, N.1
Wenzel, J.2
Wagner, I.3
Báning, J.4
Drenckhan, M.5
Zarse, K.6
-
171
-
-
0037026745
-
Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus
-
Petersen K.F., Shulman G.I. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. The American Journal of Cardiology 2002, 90:11-18.
-
(2002)
The American Journal of Cardiology
, vol.90
, pp. 11-18
-
-
Petersen, K.F.1
Shulman, G.I.2
-
172
-
-
0036307592
-
Endocannabinoids as physiological regulators of colonic propulsion in mice
-
Pinto L., Izzo A.A., Cascio M.G., Bisogno T., Hospodar-Scott K., Brown D.R., et al. Endocannabinoids as physiological regulators of colonic propulsion in mice. Gastroenterology 2002, 123:227-234.
-
(2002)
Gastroenterology
, vol.123
, pp. 227-234
-
-
Pinto, L.1
Izzo, A.A.2
Cascio, M.G.3
Bisogno, T.4
Hospodar-Scott, K.5
Brown, D.R.6
-
173
-
-
32644441249
-
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients
-
for the RIO-North America Study Group
-
Pi-Sunyer F.X., Aronne L.J., Heshmati H.M., Devin J., Rosenstock J., for the RIO-North America Study Group Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients. JAMA: The Journal of the American Medical Association 2006, 295:761-775.
-
(2006)
JAMA: The Journal of the American Medical Association
, vol.295
, pp. 761-775
-
-
Pi-Sunyer, F.X.1
Aronne, L.J.2
Heshmati, H.M.3
Devin, J.4
Rosenstock, J.5
-
174
-
-
12744260206
-
The anti-obesity effect of rimonabant is associated with an improved serum lipid profile
-
Poirier B., Bidouard J.P., Cadrouvele C., Marniquet X., Staels B., O'Connor S.E., et al. The anti-obesity effect of rimonabant is associated with an improved serum lipid profile. Diabetes, Obesity & Metabolism 2005, 7:65-72.
-
(2005)
Diabetes, Obesity & Metabolism
, vol.7
, pp. 65-72
-
-
Poirier, B.1
Bidouard, J.P.2
Cadrouvele, C.3
Marniquet, X.4
Staels, B.5
O'Connor, S.E.6
-
176
-
-
0036260823
-
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor
-
Porter A.C., Sauer J.M., Knierman M.D., Becker G.W., Berna M.J., Bao J., et al. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. The Journal of Pharmacology and Experimental Therapeutics 2002, 301:1020-1024.
-
(2002)
The Journal of Pharmacology and Experimental Therapeutics
, vol.301
, pp. 1020-1024
-
-
Porter, A.C.1
Sauer, J.M.2
Knierman, M.D.3
Becker, G.W.4
Berna, M.J.5
Bao, J.6
-
177
-
-
77955472298
-
A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: Low-dose study
-
Proietto J., Rissanen A., Harp J.B., Erondu N., Yu Q., Suryawanshi S., et al. A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: Low-dose study. International Journal of Obesity 2010, 34:1243-1254.
-
(2010)
International Journal of Obesity
, vol.34
, pp. 1243-1254
-
-
Proietto, J.1
Rissanen, A.2
Harp, J.B.3
Erondu, N.4
Yu, Q.5
Suryawanshi, S.6
-
178
-
-
69449095814
-
Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling
-
Puighermanal E., Marsicano G., Busquets-Garcia A., Lutz B., Maldonado R., Ozaita A. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nature Neuroscience 2009, 12:1152-1158.
-
(2009)
Nature Neuroscience
, vol.12
, pp. 1152-1158
-
-
Puighermanal, E.1
Marsicano, G.2
Busquets-Garcia, A.3
Lutz, B.4
Maldonado, R.5
Ozaita, A.6
-
179
-
-
77950199353
-
CB1 signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance
-
Quarta C., Bellocchio L., Mancini G., Mazza R., Cervino C., Braulke L.J., et al. CB1 signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metabolism 2010, 11:273-285.
-
(2010)
Cell Metabolism
, vol.11
, pp. 273-285
-
-
Quarta, C.1
Bellocchio, L.2
Mancini, G.3
Mazza, R.4
Cervino, C.5
Braulke, L.J.6
-
180
-
-
77957749920
-
The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior
-
Randall P.A., Vemuri V.K., Segovia K.N., Torres E.F., Hosmer S., Nunes E.J., et al. The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior. Pharmacology, Biochemistry, and Behavior 2010, 97:179-184.
-
(2010)
Pharmacology, Biochemistry, and Behavior
, vol.97
, pp. 179-184
-
-
Randall, P.A.1
Vemuri, V.K.2
Segovia, K.N.3
Torres, E.F.4
Hosmer, S.5
Nunes, E.J.6
-
181
-
-
0037304290
-
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
-
Ravinet Trillou C., Arnone M., Delgorge C., Gonalons N., Keane P., Maffrand J.P., et al. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2003, 284:R345-R353.
-
(2003)
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
, vol.284
-
-
Ravinet Trillou, C.1
Arnone, M.2
Delgorge, C.3
Gonalons, N.4
Keane, P.5
Maffrand, J.P.6
-
182
-
-
1842866963
-
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
-
Ravinet Trillou C., Delgorge C., Menet C., Arnone M., Soubrié P. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. International Journal of Obesity and Related Metabolic Disorders 2004, 28:640-648.
-
(2004)
International Journal of Obesity and Related Metabolic Disorders
, vol.28
, pp. 640-648
-
-
Ravinet Trillou, C.1
Delgorge, C.2
Menet, C.3
Arnone, M.4
Soubrié, P.5
-
183
-
-
0036015112
-
CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one)]-induced hypothermia
-
Rawls S.M., Cabassa J., Geller E.B., Adler M.W. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one)]-induced hypothermia. The Journal of Pharmacology and Experimental Therapeutics 2002, 301:963-968.
-
(2002)
The Journal of Pharmacology and Experimental Therapeutics
, vol.301
, pp. 963-968
-
-
Rawls, S.M.1
Cabassa, J.2
Geller, E.B.3
Adler, M.W.4
-
184
-
-
22844449583
-
The insulin resistance syndrome: Definition and dietary approaches to treatment
-
Reaven G.M. The insulin resistance syndrome: Definition and dietary approaches to treatment. Annual Review of Nutrition 2005, 25:391-406.
-
(2005)
Annual Review of Nutrition
, vol.25
, pp. 391-406
-
-
Reaven, G.M.1
-
185
-
-
72249112327
-
Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood-brain-barrier
-
Receveur J.M., Murray A., Linget J.M., Nørregaard P.K., Cooper M., Bjurling E., et al. Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood-brain-barrier. Bioorganic & Medicinal Chemistry Letters 2010, 20:453-457.
-
(2010)
Bioorganic & Medicinal Chemistry Letters
, vol.20
, pp. 453-457
-
-
Receveur, J.M.1
Murray, A.2
Linget, J.M.3
Nørregaard, P.K.4
Cooper, M.5
Bjurling, E.6
-
186
-
-
84855678493
-
A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men
-
Riggs P.K., Vaida F., Rossi S.S., Sorkin L.S., Gouaux B., Grant I., et al. A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men. Brain Research 2012, 1431:46-52.
-
(2012)
Brain Research
, vol.1431
, pp. 46-52
-
-
Riggs, P.K.1
Vaida, F.2
Rossi, S.S.3
Sorkin, L.S.4
Gouaux, B.5
Grant, I.6
-
187
-
-
0028129936
-
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
-
Rinaldi-Carmona M., Barth F., Héaulme M., Shire D., Calandra B., Congy C., et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Letters 1994, 350:240-244.
-
(1994)
FEBS Letters
, vol.350
, pp. 240-244
-
-
Rinaldi-Carmona, M.1
Barth, F.2
Héaulme, M.3
Shire, D.4
Calandra, B.5
Congy, C.6
-
188
-
-
33845318626
-
Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes
-
Roche R., Hoareau L., Bes-Houtmann S., Gonthier M.P., Laborde C., Baron J.F., et al. Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes. Histochemistry and Cell Biology 2006, 126:177-187.
-
(2006)
Histochemistry and Cell Biology
, vol.126
, pp. 177-187
-
-
Roche, R.1
Hoareau, L.2
Bes-Houtmann, S.3
Gonthier, M.P.4
Laborde, C.5
Baron, J.F.6
-
189
-
-
33846186286
-
Characterization of two duplicate zebrafish Cb2-like cannabinoid receptors
-
Rodriguez-Martin I., Herrero-Turrion M.J., Fdez Marron, de Velasco E., Gonzalez-Sarmiento R., Rodriguez R.E. Characterization of two duplicate zebrafish Cb2-like cannabinoid receptors. Gene 2007, 389:36-44.
-
(2007)
Gene
, vol.389
, pp. 36-44
-
-
Rodriguez-Martin, I.1
Herrero-Turrion, M.J.2
Fdez, M.3
de Velasco, E.4
Gonzalez-Sarmiento, R.5
Rodriguez, R.E.6
-
190
-
-
0030959336
-
Effects of chronic exposure to D9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions
-
Romero J., Garcia-Palomero E., Castro J.G., Garcia-Gil L., Ramos J.A., Fernandez-Ruiz J.J. Effects of chronic exposure to D9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Molecular Brain Research 1997, 46:100-108.
-
(1997)
Molecular Brain Research
, vol.46
, pp. 100-108
-
-
Romero, J.1
Garcia-Palomero, E.2
Castro, J.G.3
Garcia-Gil, L.4
Ramos, J.A.5
Fernandez-Ruiz, J.J.6
-
191
-
-
83455235862
-
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
-
Romero-Zerbo S.Y., Rafacho A., Díaz-Arteaga A., Suárez J., Quesada I., Imbernon M., et al. A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. The Journal of Endocrinology 2011, 211:177-185.
-
(2011)
The Journal of Endocrinology
, vol.211
, pp. 177-185
-
-
Romero-Zerbo, S.Y.1
Rafacho, A.2
Díaz-Arteaga, A.3
Suárez, J.4
Quesada, I.5
Imbernon, M.6
-
192
-
-
55749095211
-
Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins
-
Ruby M.A., Nomura D.K., Hudak C.S.S., Mangravite L.M., Chiu S., Casida J.E., et al. Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins. Proceedings of the National Academy of Sciences 2008, 105:14561-14566.
-
(2008)
Proceedings of the National Academy of Sciences
, vol.105
, pp. 14561-14566
-
-
Ruby, M.A.1
Nomura, D.K.2
Hudak, C.S.S.3
Mangravite, L.M.4
Chiu, S.5
Casida, J.E.6
-
193
-
-
35649015179
-
The orphan receptor GPR55 is a novel cannabinoid receptor
-
Ryberg E., Larsson N., SjÖgren S., Hjorth S., Hermansson N.O., Leonova J., et al. The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal of Pharmacology 2007, 152:1092-1101.
-
(2007)
British Journal of Pharmacology
, vol.152
, pp. 1092-1101
-
-
Ryberg, E.1
Larsson, N.2
Sjögren, S.3
Hjorth, S.4
Hermansson, N.O.5
Leonova, J.6
-
194
-
-
11144263163
-
Identification and characterisation of a novel splice variant of the human CB1 receptor
-
Ryberg E., Vu H.K., Larsson N., Groblewski T., Hjorth S., Elebring T., et al. Identification and characterisation of a novel splice variant of the human CB1 receptor. FEBS Letters 2005, 579:259-264.
-
(2005)
FEBS Letters
, vol.579
, pp. 259-264
-
-
Ryberg, E.1
Vu, H.K.2
Larsson, N.3
Groblewski, T.4
Hjorth, S.5
Elebring, T.6
-
195
-
-
33751001942
-
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: A randomised controlled study
-
Scheen A.J., Finer N., Hollander P., Jensen M.D., Van Gaal L.F. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: A randomised controlled study. The Lancet 2006, 368:1660-1672.
-
(2006)
The Lancet
, vol.368
, pp. 1660-1672
-
-
Scheen, A.J.1
Finer, N.2
Hollander, P.3
Jensen, M.D.4
Van Gaal, L.F.5
-
196
-
-
17444423605
-
Primary prevention of diabetes: What can be done and how much can be prevented?
-
Schulze M.B., Hu F.B. Primary prevention of diabetes: What can be done and how much can be prevented?. Annual Review of Public Health 2005, 26:445-467.
-
(2005)
Annual Review of Public Health
, vol.26
, pp. 445-467
-
-
Schulze, M.B.1
Hu, F.B.2
-
197
-
-
0029956258
-
Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor
-
Shire D., Calandra B., Rinaldi-Carmona M., Oustric D., Pessègue B., Bonnin-Cabanne O., et al. Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. Biochimica et Biophysica Acta 1996, 1307:132-136.
-
(1996)
Biochimica et Biophysica Acta
, vol.1307
, pp. 132-136
-
-
Shire, D.1
Calandra, B.2
Rinaldi-Carmona, M.3
Oustric, D.4
Pessègue, B.5
Bonnin-Cabanne, O.6
-
198
-
-
0028931849
-
An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing
-
Shire D., Carillon C., Kaghad M., Calandra B., Rinaldi-Carmona M., Fur G.L., et al. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. The Journal of Biological Chemistry 1995, 270:3726-3731.
-
(1995)
The Journal of Biological Chemistry
, vol.270
, pp. 3726-3731
-
-
Shire, D.1
Carillon, C.2
Kaghad, M.3
Calandra, B.4
Rinaldi-Carmona, M.5
Fur, G.L.6
-
199
-
-
48249095521
-
Feeding induced by cannabinoids is mediated independently of the melanocortin system
-
Sinnayah P., Jobst E.E., Rathner J.A., Caldera-Siu A.D., Tonelli-Lemos L., Eusterbrock A.J., et al. Feeding induced by cannabinoids is mediated independently of the melanocortin system. PLoS One 2008, 3:e2202.
-
(2008)
PLoS One
, vol.3
-
-
Sinnayah, P.1
Jobst, E.E.2
Rathner, J.A.3
Caldera-Siu, A.D.4
Tonelli-Lemos, L.5
Eusterbrock, A.J.6
-
200
-
-
0015650106
-
Influence of tetrahydrocannabinols (Δ8-THC and Δ9-THC) on body weight, food, and water intake in rats
-
SjÖdén P.O., Järbe T.U.C., Henriksson B.G. Influence of tetrahydrocannabinols (Δ8-THC and Δ9-THC) on body weight, food, and water intake in rats. Pharmacology, Biochemistry, and Behavior 1973, 1:395-399.
-
(1973)
Pharmacology, Biochemistry, and Behavior
, vol.1
, pp. 395-399
-
-
Sjödén, P.O.1
Järbe, T.U.C.2
Henriksson, B.G.3
-
201
-
-
0035087553
-
Zebra finch CB1 cannabinoid receptor: Pharmacology and in vivo and in vitro effects of activation
-
Soderstrom K., Johnson F. Zebra finch CB1 cannabinoid receptor: Pharmacology and in vivo and in vitro effects of activation. The Journal of Pharmacology and Experimental Therapeutics 2001, 297:189-197.
-
(2001)
The Journal of Pharmacology and Experimental Therapeutics
, vol.297
, pp. 189-197
-
-
Soderstrom, K.1
Johnson, F.2
-
202
-
-
0033625543
-
Behavioral, pharmacological, and molecular characterization of an amphibian cannabinoid receptor
-
Soderstrom K., Leid M., Moore F.L., Murray T.F. Behavioral, pharmacological, and molecular characterization of an amphibian cannabinoid receptor. Journal of Neurochemistry 2000, 75:413-423.
-
(2000)
Journal of Neurochemistry
, vol.75
, pp. 413-423
-
-
Soderstrom, K.1
Leid, M.2
Moore, F.L.3
Murray, T.F.4
-
203
-
-
0016285821
-
Acute and chronic effects of δ9-tetrahydrocannabinol on food intake by rats
-
Sofia R.D., Barry H. Acute and chronic effects of δ9-tetrahydrocannabinol on food intake by rats. Psychopharmacology 1974, 39:213-222.
-
(1974)
Psychopharmacology
, vol.39
, pp. 213-222
-
-
Sofia, R.D.1
Barry, H.2
-
204
-
-
77949539755
-
Peripherally acting CB1-receptor antagonist: The relative importance of central and peripheral CB1 receptors in adiposity control
-
Son M.H., Kim H.D., Chae Y.N., Kim M.K., Shin C.Y., Ahn G.J., et al. Peripherally acting CB1-receptor antagonist: The relative importance of central and peripheral CB1 receptors in adiposity control. International Journal of Obesity 2010, 34:547-556.
-
(2010)
International Journal of Obesity
, vol.34
, pp. 547-556
-
-
Son, M.H.1
Kim, H.D.2
Chae, Y.N.3
Kim, M.K.4
Shin, C.Y.5
Ahn, G.J.6
-
205
-
-
79954629673
-
Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice
-
Song D., Bandsma R., Xiao C., Xi L., Shao W., Jin T., et al. Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice. Diabetologia 2011, 54:1181-1189.
-
(2011)
Diabetologia
, vol.54
, pp. 1181-1189
-
-
Song, D.1
Bandsma, R.2
Xiao, C.3
Xi, L.4
Shao, W.5
Jin, T.6
-
206
-
-
34547574943
-
Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus
-
Soria-GÓmez E., Matias I., Rueda-Orozco P.E., Cisneros M., Petrosino S., Navarro L., et al. Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. British Journal of Pharmacology 2007, 151:1109-1116.
-
(2007)
British Journal of Pharmacology
, vol.151
, pp. 1109-1116
-
-
Soria-GÓmez, E.1
Matias, I.2
Rueda-Orozco, P.E.3
Cisneros, M.4
Petrosino, S.5
Navarro, L.6
-
207
-
-
13044311373
-
Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice
-
Steiner H., Bonner T.I., Zimmer A.M., Kitai S.T., Zimmer A. Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice. Proceedings of the National Academy of Sciences 1999, 96:5786-5790.
-
(1999)
Proceedings of the National Academy of Sciences
, vol.96
, pp. 5786-5790
-
-
Steiner, H.1
Bonner, T.I.2
Zimmer, A.M.3
Kitai, S.T.4
Zimmer, A.5
-
208
-
-
0028970517
-
2-Arachidonoylgylcerol: A possible endogenous cannabinoid receptor ligand in brain
-
Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., et al. 2-Arachidonoylgylcerol: A possible endogenous cannabinoid receptor ligand in brain. Biochemical and Biophysical Research Communications 1995, 215:89-97.
-
(1995)
Biochemical and Biophysical Research Communications
, vol.215
, pp. 89-97
-
-
Sugiura, T.1
Kondo, S.2
Sukagawa, A.3
Nakane, S.4
Shinoda, A.5
Itoh, K.6
-
209
-
-
77955286305
-
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
-
Tam J., Vemuri V.K., Liu J., Bátkai S., Mukhopadhyay B., Godlewski G., et al. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity. The Journal of Clinical Investigation 2010, 120:2953-2966.
-
(2010)
The Journal of Clinical Investigation
, vol.120
, pp. 2953-2966
-
-
Tam, J.1
Vemuri, V.K.2
Liu, J.3
Bátkai, S.4
Mukhopadhyay, B.5
Godlewski, G.6
-
210
-
-
79955958008
-
Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance
-
Taschler U., Radner F.P.W., Heier C., Schreiber R., Schweiger M., Schoiswohl G., et al. Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. The Journal of Biological Chemistry 2011, 286:17467-17477.
-
(2011)
The Journal of Biological Chemistry
, vol.286
, pp. 17467-17477
-
-
Taschler, U.1
Radner, F.P.W.2
Heier, C.3
Schreiber, R.4
Schweiger, M.5
Schoiswohl, G.6
-
211
-
-
33745003240
-
CB1 cannabinoid receptor antagonism: A new strategy for the treatment of liver fibrosis
-
Teixeira-Clerc F., Julien B., Grenard P., Van Nhieu J.T., Deveaux V., Li L., et al. CB1 cannabinoid receptor antagonism: A new strategy for the treatment of liver fibrosis. Nature Medicine 2006, 12:671-676.
-
(2006)
Nature Medicine
, vol.12
, pp. 671-676
-
-
Teixeira-Clerc, F.1
Julien, B.2
Grenard, P.3
Van Nhieu, J.T.4
Deveaux, V.5
Li, L.6
-
212
-
-
45449103422
-
The cannabinoid CB1 receptor is expressed in pancreatic δ-cells
-
Tharp W.G., Lee Y.H., Maple R.L., Pratley R.E. The cannabinoid CB1 receptor is expressed in pancreatic δ-cells. Biochemical and Biophysical Research Communications 2008, 372:595-600.
-
(2008)
Biochemical and Biophysical Research Communications
, vol.372
, pp. 595-600
-
-
Tharp, W.G.1
Lee, Y.H.2
Maple, R.L.3
Pratley, R.E.4
-
213
-
-
0017295234
-
Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue
-
Tornqvist H., Belfrage P. Purification and some properties of a monoacylglycerol-hydrolyzing enzyme of rat adipose tissue. The Journal of Biological Chemistry 1976, 251:813-819.
-
(1976)
The Journal of Biological Chemistry
, vol.251
, pp. 813-819
-
-
Tornqvist, H.1
Belfrage, P.2
-
214
-
-
79955635993
-
Role of cannabinoid receptors in alcoholic hepatic injury: Steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts
-
Trebicka J., Racz I., Siegmund S.V., Cara E., Granzow M., Schierwagen R., et al. Role of cannabinoid receptors in alcoholic hepatic injury: Steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts. Liver International 2011, 31:860-870.
-
(2011)
Liver International
, vol.31
, pp. 860-870
-
-
Trebicka, J.1
Racz, I.2
Siegmund, S.V.3
Cara, E.4
Granzow, M.5
Schierwagen, R.6
-
215
-
-
0031929438
-
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
-
Tsou K., Brown S., Sañudo-Peña M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1997, 83:393-411.
-
(1997)
Neuroscience
, vol.83
, pp. 393-411
-
-
Tsou, K.1
Brown, S.2
Sañudo-Peña, M.C.3
Mackie, K.4
Walker, J.M.5
-
217
-
-
77958571316
-
Hepatitis C virus induces the cannabinoid receptor 1
-
van der Poorten D., Shahidi M., Tay E., Sesha J., Tran K., McLeod D., et al. Hepatitis C virus induces the cannabinoid receptor 1. PLoS One 2010, 5:e12841.
-
(2010)
PLoS One
, vol.5
-
-
van der Poorten, D.1
Shahidi, M.2
Tay, E.3
Sesha, J.4
Tran, K.5
McLeod, D.6
-
218
-
-
51749109070
-
Prejunctional and peripheral effects of the cannabinoid CB1 receptor inverse agonist rimonabant (SR 141716)
-
van Diepen H., Schlicker E., Michel M. Prejunctional and peripheral effects of the cannabinoid CB1 receptor inverse agonist rimonabant (SR 141716). Naunyn-Schmiedeberg's Archives of Pharmacology 2008, 378:345-369.
-
(2008)
Naunyn-Schmiedeberg's Archives of Pharmacology
, vol.378
, pp. 345-369
-
-
van Diepen, H.1
Schlicker, E.2
Michel, M.3
-
219
-
-
42449136138
-
Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: Two year results from the RIO-Europe Study
-
Van Gaal L.F., Scheen A.J., Rissanen A.M., RÖssner S., Hanotin C., Ziegler O. Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: Two year results from the RIO-Europe Study. European Heart Journal 2008, 29:1761-1771.
-
(2008)
European Heart Journal
, vol.29
, pp. 1761-1771
-
-
Van Gaal, L.F.1
Scheen, A.J.2
Rissanen, A.M.3
Rössner, S.4
Hanotin, C.5
Ziegler, O.6
-
220
-
-
58849117501
-
The effects of rimonabant on brown adipose tissue in rat: Implications for energy expenditure
-
Verty A.N.A., Allen A.M., Oldfield B.J. The effects of rimonabant on brown adipose tissue in rat: Implications for energy expenditure. Obesity 2008, 17:254-261.
-
(2008)
Obesity
, vol.17
, pp. 254-261
-
-
Verty, A.N.A.1
Allen, A.M.2
Oldfield, B.J.3
-
221
-
-
4143144159
-
The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Δ9-tetrahydrocannabinol
-
Verty A.N.A., McGregor I.S., Mallet P.E. The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Δ9-tetrahydrocannabinol. Brain Research 2004, 1020:188-195.
-
(2004)
Brain Research
, vol.1020
, pp. 188-195
-
-
Verty, A.N.A.1
McGregor, I.S.2
Mallet, P.E.3
-
222
-
-
0038070321
-
Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats
-
Vickers S.P., Webster L.J., Wyatt A., Dourish C.T., Kennett G.A. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology 2003, 167:103-111.
-
(2003)
Psychopharmacology
, vol.167
, pp. 103-111
-
-
Vickers, S.P.1
Webster, L.J.2
Wyatt, A.3
Dourish, C.T.4
Kennett, G.A.5
-
223
-
-
78649954020
-
A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet
-
Wadden T.A., Fujioka K., Toubro S., Gantz I., Erondu E., Chen M., et al. A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet. Obesity 2010, 18:2301-2310.
-
(2010)
Obesity
, vol.18
, pp. 2301-2310
-
-
Wadden, T.A.1
Fujioka, K.2
Toubro, S.3
Gantz, I.4
Erondu, E.5
Chen, M.6
-
224
-
-
79953007668
-
Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellum
-
Wang X., Horswill J.G., Whalley B.J., Stephens G.J. Effects of the allosteric antagonist 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea (PSNCBAM-1) on CB1 receptor modulation in the cerebellum. Molecular Pharmacology 2011, 79:758-767.
-
(2011)
Molecular Pharmacology
, vol.79
, pp. 758-767
-
-
Wang, X.1
Horswill, J.G.2
Whalley, B.J.3
Stephens, G.J.4
-
225
-
-
79952008057
-
Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity
-
Wang Q., Perrard X.D., Perrard J.L., Mansoori A., Smith C.W., Ballantyne C.M., et al. Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity. Obesity 2011, 19:505-513.
-
(2011)
Obesity
, vol.19
, pp. 505-513
-
-
Wang, Q.1
Perrard, X.D.2
Perrard, J.L.3
Mansoori, A.4
Smith, C.W.5
Ballantyne, C.M.6
-
226
-
-
72049098786
-
Thrift: A guide to thrifty genes, thrifty phenotypes and thrifty norms
-
Wells J.C.K. Thrift: A guide to thrifty genes, thrifty phenotypes and thrifty norms. International Journal of Obesity 2009, 33:1331-1338.
-
(2009)
International Journal of Obesity
, vol.33
, pp. 1331-1338
-
-
Wells, J.C.K.1
-
227
-
-
0032936642
-
Anandamide induces overeating: Mediation by central cannabinoid (CB1) receptors
-
Williams C.M., Kirkham T.C. Anandamide induces overeating: Mediation by central cannabinoid (CB1) receptors. Psychopharmacology 1999, 143:315-317.
-
(1999)
Psychopharmacology
, vol.143
, pp. 315-317
-
-
Williams, C.M.1
Kirkham, T.C.2
-
228
-
-
0036607403
-
Observational analysis of feeding induced by Δ9-THC and anandamide
-
Williams C.M., Kirkham T.C. Observational analysis of feeding induced by Δ9-THC and anandamide. Physiology & Behavior 2002, 76:241-250.
-
(2002)
Physiology & Behavior
, vol.76
, pp. 241-250
-
-
Williams, C.M.1
Kirkham, T.C.2
-
229
-
-
0036361973
-
Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine
-
Williams C.M., Kirkham T.C. Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacology, Biochemistry, and Behavior 2002, 71:333-340.
-
(2002)
Pharmacology, Biochemistry, and Behavior
, vol.71
, pp. 333-340
-
-
Williams, C.M.1
Kirkham, T.C.2
-
231
-
-
0030823213
-
The biodisposition and metabolism of anandamide in mice
-
Willoughby K.A., Moore S.F., Martin B.R., Ellis E.F. The biodisposition and metabolism of anandamide in mice. The Journal of Pharmacology and Experimental Therapeutics 1997, 282:243-247.
-
(1997)
The Journal of Pharmacology and Experimental Therapeutics
, vol.282
, pp. 243-247
-
-
Willoughby, K.A.1
Moore, S.F.2
Martin, B.R.3
Ellis, E.F.4
-
232
-
-
0017129553
-
9-Nor-9-hydroxyhexahydrocannabinols. Synthesis, some behavioral and analgesic properties, and comparison with the tetrahydrocannabinols
-
Wilson R.S., May E.L., Martin B.R., Dewey W.L. 9-Nor-9-hydroxyhexahydrocannabinols. Synthesis, some behavioral and analgesic properties, and comparison with the tetrahydrocannabinols. Journal of Medicinal Chemistry 1976, 19:1165-1167.
-
(1976)
Journal of Medicinal Chemistry
, vol.19
, pp. 1165-1167
-
-
Wilson, R.S.1
May, E.L.2
Martin, B.R.3
Dewey, W.L.4
-
233
-
-
70149106339
-
Adipose-specific phospholipase as regulator of adiposity
-
Wolf G. Adipose-specific phospholipase as regulator of adiposity. Nutrition Reviews 2009, 67:551-554.
-
(2009)
Nutrition Reviews
, vol.67
, pp. 551-554
-
-
Wolf, G.1
-
234
-
-
0030219719
-
Molecular cloning of two cannabinoid type 1-like receptor genes from the puffer fish Fugu rubripes
-
Yamaguchi F., Macrae A.D., Brenner S. Molecular cloning of two cannabinoid type 1-like receptor genes from the puffer fish Fugu rubripes. Genomics 1996, 35:603-605.
-
(1996)
Genomics
, vol.35
, pp. 603-605
-
-
Yamaguchi, F.1
Macrae, A.D.2
Brenner, S.3
-
235
-
-
79952793112
-
Obesity prevalence in the United States: Up, down, or sideways?
-
Yanovski S.Z., Yanovski J.A. Obesity prevalence in the United States: Up, down, or sideways?. The New England Journal of Medicine 2011, 364:987-989.
-
(2011)
The New England Journal of Medicine
, vol.364
, pp. 987-989
-
-
Yanovski, S.Z.1
Yanovski, J.A.2
-
236
-
-
77956253088
-
Genome-wide expression profiling revealed peripheral effects of cannabinoid receptor 1 inverse agonists in improving insulin sensitivity and metabolic parameters
-
Zhao W., Fong O., Muise E.S., Thompson J.R., Weingarth D., Qian S., et al. Genome-wide expression profiling revealed peripheral effects of cannabinoid receptor 1 inverse agonists in improving insulin sensitivity and metabolic parameters. Molecular Pharmacology 2010, 78:350-359.
-
(2010)
Molecular Pharmacology
, vol.78
, pp. 350-359
-
-
Zhao, W.1
Fong, O.2
Muise, E.S.3
Thompson, J.R.4
Weingarth, D.5
Qian, S.6
-
237
-
-
0033545866
-
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
-
Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proceedings of the National Academy of Sciences 1999, 96:5780-5785.
-
(1999)
Proceedings of the National Academy of Sciences
, vol.96
, pp. 5780-5785
-
-
Zimmer, A.1
Zimmer, A.M.2
Hohmann, A.G.3
Herkenham, M.4
Bonner, T.I.5
-
238
-
-
0027231337
-
Early medical use of cannabis
-
Zlas J., Stark H., Seligman J., Levy R., Werker E., Breuer A., et al. Early medical use of cannabis. Nature 1993, 363:215.
-
(1993)
Nature
, vol.363
, pp. 215
-
-
Zlas, J.1
Stark, H.2
Seligman, J.3
Levy, R.4
Werker, E.5
Breuer, A.6
|